| For: | Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 2018; 24(34): 3834-3848 [PMID: 30228778 DOI: 10.3748/wjg.v24.i34.3834] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i34/3834.htm |
| Number | Citing Articles |
| 1 |
Hang Zheng, Heshu Liu, Yang Ge, Xin Wang. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02252-9
|
| 2 |
Dexin Deng, Yingxue Yang, Yurong Zou, Kongjun Liu, Chufeng Zhang, Minghai Tang, Tao Yang, Yong Chen, Xue Yuan, Yong Guo, Shunjie Zhang, Wenting Si, Bin Peng, Qing Xu, Wen He, Dingguo Xu, Mingli Xiang, Lijuan Chen. Discovery and Evaluation of 3-Quinoxalin Urea Derivatives as Potent, Selective, and Orally Available ATM Inhibitors Combined with Chemotherapy for the Treatment of Cancer via Goal-Oriented Molecule Generation and Virtual Screening. Journal of Medicinal Chemistry 2023; 66(14) doi: 10.1021/acs.jmedchem.3c00082
|
| 3 |
Weiyan Zou, Jie Zhao, Yi Li, Zishu Wang, Haiqin Yan, Yudong Liu, Meiqun Sun, Jialu Zhuang, Junbin Wang. <p>Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S249353
|
| 4 |
Daoqi Zhu, Yiping Jiang, Huihui Cao, Jiabin Yang, Yuqi Shu, Haowei Feng, Xiaoyu Yang, Xiaomin Sun, Meng Shao. Lactate: A regulator of immune microenvironment and a clinical prognosis indicator in colorectal cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.876195
|
| 5 |
V. P. Shubin, S. I. Achkasov, O. I. Sushkov, A. S. Tsukanov. MOLECULAR-GENETIC FEATURES OF COLORECTAL TUMORS IN PERITONEAL CARCINOMATOSIS AND LIVER METASTASES (review). Koloproktologia 2020; 19(4) doi: 10.33878/2073-7556-2020-19-4-177-187
|
| 6 |
Yaser Ebrahimi, Jafar Rezaie, Ali Akbari, Yousef Rasmi. Green hydrothermal synthesis of gallic acid carbon dots: characterization and cytotoxic effects on colorectal cancer cell line. Biomedical Physics & Engineering Express 2025; 11(1) doi: 10.1088/2057-1976/ad9153
|
| 7 |
Jose D. Puentes-Pardo, Sara Moreno-SanJuan, Jorge Casado, Julia Escudero-Feliu, David López-Pérez, Paula Sánchez-Uceta, Paula González-Novoa, Julio Gálvez, Ángel Carazo, Josefa León. PARP-1 Expression Influences Cancer Stem Cell Phenotype in Colorectal Cancer Depending on p53. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054787
|
| 8 |
Peng Ouyang, Jin Gong, Jinlin Nie, Sridhar Kandala, Yangdong Shi, Yao Tian, Zhijing Zhang, Sifu Fang, Fan Pan, Lin Qiu, Zhen Bao. Tamarixetin Suppresses Colorectal Cancer Progression by Targeting DPP7‐Mediated WNT3A/β‐Catenin Signalling Pathway. Journal of Cellular and Molecular Medicine 2025; 29(16) doi: 10.1111/jcmm.70787
|
| 9 |
Daniella Paiva Bonfim, Celso Vataru Nakamura, João Xavier de Araújo Júnior, Greisiele Lorena Pessini, Paulo Emílio Correa Leite, José Andrés Morgado‐Díaz, Fernanda Leve. Kopsanone inhibits proliferation and migration of invasive colon cancer cells. Phytotherapy Research 2021; 35(7) doi: 10.1002/ptr.7078
|
| 10 |
Paula Sánchez‐Olivares, Aniela M. Silva‐Nolasco, Miguel A. de la Cruz‐Morcillo, María Mercedes García‐Martínez, Alejandro Pinedo‐Serrano, Manuel Carmona, Eva M. Galán‐Moya. Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models. Journal of Cellular and Molecular Medicine 2024; 28(24) doi: 10.1111/jcmm.70294
|
| 11 |
Xiao-Lan Jian, Pu-Hua Zeng, Ke-Xiong Li, Wei Peng. FGF2 promotes the chemotherapy resistance in colon cancer cells through activating PI3K/Akt signaling pathway. Oncology and Translational Medicine 2023; 9(6) doi: 10.1097/ot9.0000000000000018
|
| 12 |
Zari Salahud Din, Maryam Saqib, Sehrish Zafar, Nyla Munawar, Sagheer Ahmed.
Variation in the
ABC
transporter genes and association with clinical outcomes in colorectal cancer: a brief review
. Pharmacogenomics 2025; 26(7-9) doi: 10.1080/14622416.2025.2534319
|
| 13 |
Silvia Mola, Chiara Pandolfo, Antonio Sica, Chiara Porta. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. International Journal of Molecular Sciences 2020; 21(18) doi: 10.3390/ijms21186866
|
| 14 |
Mo Zhu, Baofei Jiang, Dongsheng Yan, Xiaopeng Wang, Hengfa Ge, Yueming Sun. Knockdown of TMEM45A overcomes multidrug resistance and epithelial–mesenchymal transition in human colorectal cancer cells through inhibition of TGF‐β signalling pathway. Clinical and Experimental Pharmacology and Physiology 2020; 47(3) doi: 10.1111/1440-1681.13220
|
| 15 |
Haixia Yan, Qinling Ou, Yonglong Chang, Jinhui Liu, Linzi Chen, Duanyang Guo, Sifang Zhang. 5-Fluorouracil resistance-based immune-related gene signature for COAD prognosis. Heliyon 2024; 10(14) doi: 10.1016/j.heliyon.2024.e34535
|
| 16 |
Natasha Naval Aggarwal, S.M. Sindhoor, N. Raghavendra Naveen, Buduru Gowthami, Prajitha Biju. Drug Reprofiling: A Prospective Approach to Battle Chronic Ailments. Journal of Health and Allied Sciences NU 2024; 14(01) doi: 10.1055/s-0043-1769903
|
| 17 |
Keita Koizumi, Takahiro Domoto, Toshinari Minamoto, Kazuhito Kazuhito, Hideo Nakajima. Deactivation of glycogen synthase kinase-3β by heat shock‑inducible tumor small protein attenuates hyperthermia‑induced pro‑migratory activity in colorectal cancer cells. International Journal of Oncology 2023; 63(2) doi: 10.3892/ijo.2023.5540
|
| 18 |
Qiqi Zhang, Zhan Wang, Zhenghua Zhang, Lifei Zhu, Xijing Yang. Analysis of microarray-identified genes and MicroRNAs associated with Trifluridine resistance in colorectal cancer. All Life 2022; 15(1) doi: 10.1080/26895293.2022.2080280
|
| 19 |
Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba, Shutong Liu, Hui Xu, Yuyuan Zhang, Siyuan Weng, Zhaokai Zhou, Long Liu, Peng Luo, Quan Cheng, Chuhan Zhang, Yukang Chen, Dan Shan, Benyu Liu, Shuaixi Yang, Xinwei Han, Jinhai Deng, Zaoqu Liu. THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02180-y
|
| 20 |
Laura Bracci, Alessia Fabbri, Manuela Del Cornò, Lucia Conti. Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies. Cancers 2021; 13(18) doi: 10.3390/cancers13184499
|
| 21 |
Jovana Petrović, Jasmina Glamočlija, Tatjana Ilić-Tomić, Marina Soković, Dragana Robajac, Olgica Nedić, Aleksandar Pavić. Lectin from Laetiporus sulphureus effectively inhibits angiogenesis and tumor development in the zebrafish xenograft models of colorectal carcinoma and melanoma. International Journal of Biological Macromolecules 2020; 148 doi: 10.1016/j.ijbiomac.2020.01.033
|
| 22 |
Lianghui Zhi, Lianmei Zhao, Xue Zhang, Wei Liu, Bo Gao, Feifei Wang, Xiaoran Wang, Guiying Wang. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging 2021; 13(18) doi: 10.18632/aging.203502
|
| 23 |
Jin-Hee Kwon, Na-Gyeong Lee, A-Ram Kang, In-Ho Ahn, In-Young Choi, Jie-Young Song, Sang-Gu Hwang, Hong-Duck Um, Jong-Ryoo Choi, Joon Kim, Jong Kuk Park. JNC-1043, a Novel Podophyllotoxin Derivative, Exerts Anticancer Drug and Radiosensitizer Effects in Colorectal Cancer Cells. Molecules 2022; 27(20) doi: 10.3390/molecules27207008
|
| 24 |
Jiangning Li, Xiaofeng Li. Encorafenib inhibits migration, induces cell cycle arrest and apoptosis in colorectal cancer cells. Molecular and Cellular Biochemistry 2019; 459(1-2) doi: 10.1007/s11010-019-03554-3
|
| 25 |
Yingyu ZHOU. Bioinformatics Analysis of Biomarkers and Functional Natural Products. KAGAKU TO SEIBUTSU 2023; 61(9) doi: 10.1271/kagakutoseibutsu.61.410
|
| 26 |
Danmei Yu, Zhou Lu, Ruyu Wang, Yusen Xiang, Hongtao Li, Jiani Lu, Lijun Zhang, Hongzhuan Chen, Weihua Li, Xin Luan, Lili Chen. FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy. Biochemical Pharmacology 2023; 212 doi: 10.1016/j.bcp.2023.115570
|
| 27 |
Mahshid Mohammadian, Shima Zeynali-Moghaddam, Mohammad Hassan Khadem Ansari, Yousef Rasmi, Anahita Fathi Azarbayjani, Fatemeh Kheradmand. Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine. Advanced Pharmaceutical Bulletin 2019; 9(3) doi: 10.15171/apb.2019.052
|
| 28 |
Archana Katoch, Debasis Nayak, Mir Mohd. Faheem, Aviral Kumar, Promod Kumar Sahu, Ajai Prakash Gupta, Lekha Dinesh Kumar, Anindya Goswami. Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00405-3
|
| 29 |
Xi Zhao, Xiaoqiang Qi, Wenrui Lian, Xin Tong, Hua Wang, Liya Su, Ping Wei, Zhuochen Zhuang, Jianhua Gong, Liping Bai. Trichomicin Suppresses Colorectal Cancer via Comprehensive Regulation of IL-6 and TNFα in Tumor Cells, TAMs, and CAFs. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00386
|
| 30 |
Cheng-Chin Lee, Ai-Wei Lee, Po-Li Wei, Yi-Shin Liu, Yu-Jia Chang, Chien-Yu Huang. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-31331-2
|
| 31 |
Tse-Hung Huang, Ntlotlang Mokgautsi, Yan-Jiun Huang, Alexander T. H. Wu, Hsu-Shan Huang. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects. Cells 2021; 10(8) doi: 10.3390/cells10081970
|
| 32 |
Guanglong Chen, Ting Gong, Zhe Wang, Zeyu Wang, Xiaolin Lin, Sunrui Chen, Chu Sun, Weijie Zhao, Ye Kong, Huihan Ai, Hang Yang, Yusheng Liu, Fangyan Wu, Jiawei Kang, Shasha Zhao, Xiuying Xiao, Jing Sun, Aina He, Zhi Li. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cellular Oncology 2022; doi: 10.1007/s13402-022-00705-5
|
| 33 |
Bo Kang, Xiaobing Zhang, Weibing Wang, Shiqi She, Wenjie Chen, Cheng Chen, Yisha Wang, Xiaoyun Pan, Ouyuan Xu, Yingjie Wang. The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer. Cancers 2022; 14(23) doi: 10.3390/cancers14235747
|
| 34 |
Yinghui Zhao, Chuanxin Wang, Ajay Goel. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis 2021; 42(6) doi: 10.1093/carcin/bgab027
|
| 35 |
Mehran Molavand, Majid Montazer, Somayyeh Ghareghomi, Bahman Yousefi, Maryam Majidinia. The involvement of major signaling pathways in metastasis of colorectal cancer and the therapeutic application of their inhibitors. Expert Review of Anticancer Therapy 2025; 25(8) doi: 10.1080/14737140.2025.2519860
|
| 36 |
Rabin Neupane, Saloni Malla, Mariam Sami Abou-Dahech, Swapnaa Balaji, Shikha Kumari, Digambar Kumar Waiker, N. S. Hari Narayana Moorthy, Piyush Trivedi, Charles R. Ashby, Chandrabose Karthikeyan, Amit K. Tiwari. Antiproliferative Efficacy of N-(3-chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine, DW-8, in Colon Cancer Cells Is Mediated by Intrinsic Apoptosis. Molecules 2021; 26(15) doi: 10.3390/molecules26154417
|
| 37 |
Tahani Bakhsh, Tamer S. Saleh, Dalal A. Al-Saedi, Khadijah M. Al-Zaydi. Design, synthesis, and in silico studies of novel di-(2-aryl hydrozonopropanal) arene derivatives as potent anticancer for targeting A2AR and LRP6 in HCT116 cell. Medicinal Chemistry Research 2024; 33(1) doi: 10.1007/s00044-023-03164-1
|
| 38 |
Ruiyun Wu, Pinglan Li, Yi Wang, Nan Su, Mengyuan Xiao, Xiaojun Li, Nan Shang. Structural analysis and anti-cancer activity of low-molecular-weight chondroitin sulfate from hybrid sturgeon cartilage. Carbohydrate Polymers 2022; 275 doi: 10.1016/j.carbpol.2021.118700
|
| 39 |
Sen Hong, Zhenkun Yan, YuMei Song, MiaoMiao Bi, Shiquan Li. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer. Aging 2020; 12(6) doi: 10.18632/aging.102940
|
| 40 |
Seyed Samad Hosseini, Paria Nazifi, Mohammad Amini, Felor Zargari, Amir Hossein Yari, Behzad Baradaran, Soltanali Mahboob, Ahad Mokhtarzadeh. Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145
and KRAS/RREB1 Pathways. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(17) doi: 10.2174/1871520623666230718145100
|
| 41 |
Wenzhe Gu, Zhengjie Shen. Matrine inhibits miR-181a-mediated chemoresistance in rectal cancer. Materials Express 2023; 13(7) doi: 10.1166/mex.2023.2464
|
| 42 |
Katarzyna Kaczmarek, Jerzy Więckiewicz, Kazimierz Węglarczyk, Maciej Siedlar, Jarek Baran. The Anti-Tumor Effect of Lactococcus lactis Bacteria-Secreting Human Soluble TRAIL Can Be Enhanced by Metformin Both In Vitro and In Vivo in a Mouse Model of Human Colorectal Cancer. Cancers 2021; 13(12) doi: 10.3390/cancers13123004
|
| 43 |
Zhifeng Wang, Jingmei Liu, Tao Yang, Qinqin Wang, Rong Liang, Jinliang Tang. Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells. Molecular and Cellular Biochemistry 2023; 478(5) doi: 10.1007/s11010-022-04551-9
|
| 44 |
Colin McGuckin, Nico Forraz, Clément Milet, Mathieu Lacroix, Yordan Sbirkov, Victoria Sarafian, Caroline Ebel, Anita Spindler, Véronique Koerper, Jean-Marc Balloul, Philippe Erbs. Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery. Cancers 2025; 17(22) doi: 10.3390/cancers17223705
|
| 45 |
Qian Hu, Wanhui Wei, Daiqian Wu, Fengxing Huang, Mengting Li, Wenjie Li, Jingwen Yin, Yanan Peng, Yuanyuan Lu, Qiu Zhao, Lan Liu. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.810327
|
| 46 |
Kirti K. Iyer, Nielka P. van Erp, Daniele V.F. Tauriello, Henk M.W. Verheul, Dennis Poel. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer. Cancer Treatment Reviews 2022; 110 doi: 10.1016/j.ctrv.2022.102466
|
| 47 |
Rayan Sabra, Nashiru Billa. Soliciting the Oral Route as a Logical Approach to Managing Colon Cancer. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.645923
|
| 48 |
Gonçalo A. Marcelo, David Montpeyó, Joana Galhano, Ramón Martínez-Máñez, José Luis Capelo-Martínez, Julia Lorenzo, Carlos Lodeiro, Elisabete Oliveira. Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(7) doi: 10.3390/ijms24076612
|
| 49 |
Soon-Chan Kim, Hyun-Soo Kim, Jae Hyeon Kim, Nahyun Jeong, Young-Kyoung Shin, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Ja-Lok Ku. Establishment and characterization of 18 human colorectal cancer cell lines. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-63812-z
|
| 50 |
Si-Jia Li, Yi-Xuan Lu, Fang-Yue Zheng, Yi-Cong Bian, Li-Yan Miao, Chen-Rong Huang. Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimens. World Journal of Gastrointestinal Oncology 2025; 17(11): 111171 doi: 10.4251/wjgo.v17.i11.111171
Abstract(81) |
Core Tip(74) |
Full Article(HTML)(231)
|
Full Article (PDF)-1804K(77)
|
Full Article with Cover (PDF)-2116K(52)
|
Full Article (XML)-87K(34)
|
Audio-907K(8)
|
Peer-Review Report-306K(37)
|
Answering Reviewers-126K(30)
|
Supplementary Material-70K(41)
|
Times Cited (0)
|
Total Visits (505)
|
Open
|
| 51 |
Sirui Long, Jie Wang, Fanbin Weng, Zhigang Pei, Shixian Zhou, Guiyin Sun, Debing Xiang. ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1005915
|
| 52 |
Wan-Jun Han. The establishment of organoids and their applications. New Discovery 2025; doi: 10.61958/NDNU9408
|
| 53 |
Pouya Goleij, Saeid Ferdousmakan, Mohammad Amin Khazeei Tabari, Alireza Amini, Danaé S Larsen, Maria Daglia, Alireza Javan, Tian Li, Haroon Khan, Yifei Xu. Targeting drug resistant colorectal cancer with apigenin nanoarchitectures. Translational Oncology 2025; 59 doi: 10.1016/j.tranon.2025.102455
|
| 54 |
Marta Sánchez-Díez, Nicolás Alegría-Aravena, Marta López-Montes, Josefa Quiroz-Troncoso, Raquel González-Martos, Adrián Menéndez-Rey, José Luis Sánchez-Sánchez, Juan Manuel Pastor, Carmen Ramírez-Castillejo. Implication of Different Tumor Biomarkers in Drug Resistance and Invasiveness in Primary and Metastatic Colorectal Cancer Cell Lines. Biomedicines 2022; 10(5) doi: 10.3390/biomedicines10051083
|
| 55 |
Nima Zeinali, Vahid Mahmoudzadeh, Alireza Anarjani, Mohammad Ebrahimnejad, Bahman Yousefi, Amir Valizadeh, Sercan Ergün. Thymoquinone Increases the Sensitivity of SW‐480 Colon Cancer Cells to 5‐Fluorouracil. BioMed Research International 2024; 2024(1) doi: 10.1155/2024/6231095
|
| 56 |
S.P.D. Ponamgi, Sujatha Peela. Epigenetic Regulations in Gastrointestinal Cancers. 2026; doi: 10.1016/B978-0-443-27765-8.00009-6
|
| 57 |
Cherie Ann Kruger, Heidi Abrahamse. Multidisciplinary Approach for Colorectal Cancer. 2019; doi: 10.5772/intechopen.84760
|
| 58 |
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00020-X
|
| 59 |
Jiali Cai, Die Hu, Judy Sakya, Tao Sun, Daoyong Wang, Lin Wang, Xiaohua Mao, Zhenyi Su. ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer. Cell Death & Disease 2021; 12(2) doi: 10.1038/s41419-021-03427-y
|
| 60 |
Jong Won Lee, Young Soo Park, Jung Yoon Choi, Won Jin Chang, Soohyeon Lee, Jae Sook Sung, Boyeon Kim, Saet Byeol Lee, Sung Yong Lee, Jungmin Choi, Yeul Hong Kim. Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.843561
|
| 61 |
Yanting Lin, Yiming Liu, Zhenhua Gao, Dongquan Jing, Ran Bi, Xinmeng Cui, Qiuhua Cao, Qixiang Zhao, Rui Gao, Yali Su, Siliang Liu, Mingrui Zhao, Yong Yang, Anqi Chen, Beiying Dai, Xinghua Gao. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer. European Journal of Pharmacology 2023; 949 doi: 10.1016/j.ejphar.2023.175718
|
| 62 |
Gaowu Hu, Wenquan Chen, Wei Peng, Zhen Huang, Zhanlin Dong, Yongqing Cao. Cincumol prevents malignant phenotype of colorectal cancer cell line HCT116 via inhibiting PI3K/AKT signaling in vitro. Acta Cirúrgica Brasileira 2022; 37(12) doi: 10.1590/acb371201
|
| 63 |
Nikolay Mehterov, Maria Kazakova, Yordan Sbirkov, Boyan Vladimirov, Nikolay Belev, Galina Yaneva, Krassimira Todorova, Soren Hayrabedyan, Victoria Sarafian. Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy. Genes 2021; 12(7) doi: 10.3390/genes12071085
|
| 64 |
Sheng-Nan Ren, Zhan-Yi Zhang, Rui-Jie Guo, Da-Ren Wang, Fang-Fang Chen, Xue-Bo Chen, Xue-Dong Fang. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. World Journal of Gastroenterology 2023; 29(13): 1911-1941 doi: 10.3748/wjg.v29.i13.1911
|
| 65 |
Vinod K. Nelson, Mohana Vamsi Nuli, Juturu Mastanaiah, Mohamed Saleem T. S., Geetha Birudala, Yahya F. Jamous, Omar Alshargi, Kranthi Kumar Kotha, Hari Hara Sudhan, Ravishankar Ram Mani, Alagusundaram Muthumanickam, Divya Niranjan, Nem Kumar Jain, Ankur Agrawal, Arvind Singh Jadon, Vinyas Mayasa, Niraj Kumar Jha, Adriana Kolesarova, Petr Slama, Shubhadeep Roychoudhury. Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1201198
|
| 66 |
Hyung-Jin Kim, Do Sang Lee, Jung Hyun Park, Ha-Eun Hong, Ho Joong Choi, Ok-Hee Kim, Say-June Kim. Exosome-based strategy against colon cancer using small interfering RNA-loaded vesicles targeting soluble a proliferation-inducing ligand. World Journal of Stem Cells 2024; 16(11): 956-973 doi: 10.4252/wjsc.v16.i11.956
|
| 67 |
Laura Mosca, Martina Pagano, Luigi Borzacchiello, Luigi Mele, Annapina Russo, Giulia Russo, Giovanna Cacciapuoti, Marina Porcelli. S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation. International Journal of Molecular Sciences 2021; 22(17) doi: 10.3390/ijms22179286
|
| 68 |
Hao Jin, Hak Sung Kim, Seung Taek Yu, Sae Ron Shin, Sung Hee Lee, Geom Seog Seo. Synergistic anticancer effect of docosahexaenoic acid and isoliquiritigenin on human colorectal cancer cells through ROS-mediated regulation of the JNK and cytochrome c release. Molecular Biology Reports 2021; 48(2) doi: 10.1007/s11033-021-06159-6
|
| 69 |
Tao Yang, Tao Guo, Yongting Yuan, Minghai Tang, Xue Cui, Min Zhao, Meng Qin, Zhuang Yang. Rational Design of Novel pyrazolo[4,3-c]quinoline Derivatives as Potent, Selective, and Orally Bioavailable ATM Inhibitors with Promising In Vivo Efficacy. Journal of Medicinal Chemistry 2026; 69(4) doi: 10.1021/acs.jmedchem.5c03290
|
| 70 |
Hasan KURTER, Janberk YEŞİL, Ezgi DASKIN, Gizem ÇALIBAŞI KOÇAL, Hülya ELLİDOKUZ, Yasemin BAŞBINAR. Drug Resistance Mechanisms on Colorectal Cancer. Journal of Basic and Clinical Health Sciences 2021; 5(1) doi: 10.30621/jbachs.869310
|
| 71 |
Chuxin Zhang. The role of apoptosis and its potential as a therapeutic target in inflammatory bowel disease associated with colorectal cancer. American Journal of Translational Research 2025; 17(7) doi: 10.62347/NCFF5626
|
| 72 |
Bao Chai, Yarong Guo, Na Zhu, Junmei Jia, Zhuowei Zhang, Mei Ping, Kai Jia, Xiaolong Cui, Yuhong Suo. Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin. Molecular Medicine Reports 2021; 24(6) doi: 10.3892/mmr.2021.12502
|
| 73 |
Xin Li, Lili Chen, Yunqiu Gao, Qiuhua Zhang, Alan K Chang, Zhe Yang, Xiuli Bi. Black raspberry anthocyanins increased the antiproliferative effects of 5-Fluorouracil and Celecoxib in colorectal cancer cells and mouse model. Journal of Functional Foods 2021; 87 doi: 10.1016/j.jff.2021.104801
|
| 74 |
Hadgu Mendefro Berehu, Anupriya S, Md Imran Khan, Rajasree Chakraborty, Kousalya Lavudi, Josthna Penchalaneni, Bibhashee Mohapatra, Amrita Mishra, Srinivas Patnaik. Cytotoxic Potential of Biogenic Zinc Oxide Nanoparticles Synthesized From Swertia chirayita Leaf Extract on Colorectal Cancer Cells. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.788527
|
| 75 |
Chiugo Okoye, My Tran, Elizabeth Soladoye, Darlington E Akahara, Chinemerem M Emeasoba, Blessing T Ojinna, Emmanuel Anasonye, Oyindamola O Obadare, Chiamaka S Diala, Bolanle H Salaudeen, Endurance O Evbayekha, Okelue E Okobi. A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. Cureus 2023; doi: 10.7759/cureus.43189
|
| 76 |
Nagaraju Bandaru, Shaik Mohammad Noor, Maha Lakshmi Kammili, Mohan Gandhi Bonthu, Alluri Pavani Gayatri, Perli Kranti Kumar. Methionine restriction for cancer therapy: A comprehensive review of mechanisms and clinical applications. Cancer Pathogenesis and Therapy 2026; 4(2) doi: 10.1016/j.cpt.2025.01.002
|
| 77 |
Jeyalakshmi Kandhavelu, Kumar Subramanian, Vivash Naidoo, Giulia Sebastianelli, Phuong Doan, Saravanan Konda Mani, Hande Yapislar, Ebru Haciosmanoglu, Leman Arslan, Samed Ozer, Ramesh Thiyagarajan, Nuno R. Candeias, Clement Penny, Meenakshisundaram Kandhavelu, Akshaya Murugesan. A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL‐2/BAX and p53 in colon cancer. British Journal of Pharmacology 2024; 181(1) doi: 10.1111/bph.16141
|
| 78 |
Anjugam Paramanantham, Min Jeong Kim, Eun Joo Jung, Hye Jung Kim, Seong-Hwan Chang, Jin-Myung Jung, Soon Chan Hong, Sung Chul Shin, Gon Sup Kim, Won Sup Lee. Anthocyanins Isolated from Vitis coignetiae Pulliat Enhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation. Molecules 2020; 25(16) doi: 10.3390/molecules25163623
|
| 79 |
Mibae Jeong, Jaemoo Chun, Sang-Min Park, Heerim Yeo, Se Won Na, In Jin Ha, Bonglee Kim, Mi-Kyung Jeong. An Investigation of the Anticancer Mechanism of Caesalpinia sappan L. Extract Against Colorectal Cancer by Integrating a Network Pharmacological Analysis and Experimental Validation. Plants 2025; 14(2) doi: 10.3390/plants14020263
|
| 80 |
Pedro Farinha, Jacinta O. Pinho, Mariana Matias, M. Manuela Gaspar. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs. Drug Delivery and Translational Research 2022; 12(1) doi: 10.1007/s13346-021-00916-7
|
| 81 |
Pengfei Zhao, Feng Li, Yongzhuo Huang. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. 2020; doi: 10.1016/B978-0-12-819937-4.00010-8
|
| 82 |
Rajendra Prasad, João Conde. Bioinspired soft nanovesicles for site‐selective cancer imaging and targeted therapies. WIREs Nanomedicine and Nanobiotechnology 2022; 14(4) doi: 10.1002/wnan.1792
|
| 83 |
Chenglong He, Wenjing Dong, Yanhua Lyu, Yan Qin, Siquan Zhong, Xiaomei Jiang, Jianjun Xiao. Molecular characteristics, clinical significance and cancer‑immune interactions of pyroptosis‑related genes in colorectal cancer. Oncology Letters 2024; 29(2) doi: 10.3892/ol.2024.14835
|
| 84 |
Ulrike Pfohl, Jürgen Loskutov, Sanum Bashir, Ralf Kühn, Patrick Herter, Markus Templin, Soulafa Mamlouk, Sergei Belanov, Michael Linnebacher, Florian Bürtin, Marcus Vetter, Christoph Reinhard, Lena Wedeken, Christian R. A. Regenbrecht. A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers 2022; 14(13) doi: 10.3390/cancers14133252
|
| 85 |
Gloria Perazzoli, Carolina de los Reyes, Cristina Pinedo-Rivilla, Rosa Durán-Patrón, Josefina Aleu, Laura Cabeza, Consolación Melguizo, Jose Prados. Emericellopsis maritima and Purpureocillium lilacinum Marine Fungi as a Source of Functional Fractions with Antioxidant and Antitumor Potential in Colorectal Cancer: A Preliminary Study. Journal of Marine Science and Engineering 2023; 11(10) doi: 10.3390/jmse11102024
|
| 86 |
Camilla Cittadini, Elisabetta Iessi, Rosa Vona, Paola Matarrese. Exploring Risk Factors and Sex Differences in Colorectal Cancer: Insights from Current Evidence. Cells 2026; 15(11) doi: 10.3390/cells15111039
|
| 87 |
Sepideh Ghani, Samira Bahrami, Behnam Rafiee, Shirin Eyvazi, Fatemeh Yarian, Shahrzad Ahangarzadeh, Saeed Khalili, Kiana Shahzamani, Moslem Jafarisani, Mojgan Bandehpour, Bahram Kazemi. Recent developments in antibody derivatives against colorectal cancer; A review. Life Sciences 2021; 265 doi: 10.1016/j.lfs.2020.118791
|
| 88 |
Zeynab Vakili-Ghartavol, Hoda Deli, Amir Shadboorestan, Roxana Sahebnasagh, Elahe Motevaseli, Mohammad Hossein Ghahremani. Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01110-y
|
| 89 |
Colin McGuckin, Nico Forraz, Clément Milet, Mathieu Lacroix, Yordan Sbirkov, Victoria Sarafian, Caroline Ebel, Anita Spindler, Véronique Koerper, Jean-Marc Balloul, Eric Quéméneur, Cécile Zaupa. World’s First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses. Cancers 2023; 15(19) doi: 10.3390/cancers15194724
|
| 90 |
Laura C. Demmers, Kai Kretzschmar, Arne Van Hoeck, Yotam E. Bar-Epraïm, Henk W. P. van den Toorn, Mandy Koomen, Gijs van Son, Joost van Gorp, Apollo Pronk, Niels Smakman, Edwin Cuppen, Hans Clevers, Albert J. R. Heck, Wei Wu. Single-cell derived tumor organoids display diversity in HLA class I peptide presentation. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-19142-9
|
| 91 |
Sasan Parvini, Jamal Majidpoor, Keywan Mortezaee. The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4. Pathology - Research and Practice 2023; 247 doi: 10.1016/j.prp.2023.154583
|
| 92 |
Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, Mariam Oladejo, Izuchukwu F. Okpalanwaka, Savanna L. Smith, Duke Appiah, Laurence M. Wood, Devin B. Lowe. Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2260620
|
| 93 |
Ralph Girson Gunarsa, Aru Wisaksono Sudoyo, Ricci Steven, Dilafitria Fauza, Fajar Lamhot Gultom, Ibrahim Basir, Dicky Kurniawan, Akterono Dwi Budiyati. The Dynamic Changes of Circulating Myeloid-Derived Suppressor Cells (MDSCs) Subsets in Colorectal Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01207-x
|
| 94 |
Yueping Zhan, Yanyan Qiu, Haijing Wang, Ziyuan Wang, Jian Xu, Guohua Fan, Jianhua Xu, Wei Li, Yijun Cao, Van‐Minh Le, Hai‐Trieu Ly, Zeting Yuan, Ke Xu, Peihao Yin. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer. Cancer Science 2020; 111(5) doi: 10.1111/cas.14345
|
| 95 |
Long‐Wei Lin, Peng‐Sheng Lai, Ying‐Yin Chen, Chung‐Yu Chen. Expression of astrocyte‐elevated gene‐1 indicates prognostic value of fluoropyrimidine‐based adjuvant chemotherapy in resectable stage III colorectal cancer. Pathology International 2021; 71(11) doi: 10.1111/pin.13160
|
| 96 |
Yang Yang, Tao Zhang, Lixiang Wu. TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT Pathway. Biochemical Genetics 2021; 59(4) doi: 10.1007/s10528-021-10051-0
|
| 97 |
Yanzhe Yue, Xiangjian She, Wenbo Ding, Shuyu Chen, Qianni Xiao, Bei Pan, Linpeng Zhou, Yujuan Yin, Youyue Li, Shukui Wang, Mu Xu. A novel Senescence-Based prognostic model unveils tumor interactions and drug resistance in colorectal cancer. International Immunopharmacology 2024; 134 doi: 10.1016/j.intimp.2024.112197
|
| 98 |
Roya Abedizadeh, Fateme Majidi, Hamid Reza Khorasani, Hassan Abedi, Davood Sabour. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer and Metastasis Reviews 2024; 43(2) doi: 10.1007/s10555-023-10158-3
|
| 99 |
Aakriti Garg, Kamal Kant, Kuldeep K. Roy, Abhishek Sahoo, Chandi C. Malakar, Sreya Gupta. Docking-based evaluation against Human Tankyrase-1 and Tankyrase-2 enzyme. Materials Today: Proceedings 2022; 57 doi: 10.1016/j.matpr.2022.03.095
|
| 100 |
Ying Yu Liang, Smaranda Bacanu, Lekshmy Sreekumar, Anderson Daniel Ramos, Lingyun Dai, Martin Michaelis, Jindrich Cinatl, Takahiro Seki, Yihai Cao, Cynthia R. Coffill, David P. Lane, Nayana Prabhu, Pär Nordlund. CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity. Cell Chemical Biology 2022; 29(4) doi: 10.1016/j.chembiol.2021.06.007
|
| 101 |
Khaidem Devika Chanu, Soibam Thoithoisana, Amit Kar, Pulok Kumar Mukherjee, P. Radhakrishnanand, Keyur Parmar, Nanaocha Sharma. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs. Journal of Ethnopharmacology 2024; 322 doi: 10.1016/j.jep.2023.117591
|
| 102 |
Lalu Muhammad Irham, Wirawan Adikusuma, Didi Nurhadi Illian, Maulida Mazaya, Alfian Mubaraq, Muhammad Ma’ruf, Novi Kurnia Rizki, Maya Sari Mutia, Hayssam M. Ali, Mohammad Basyuni. Deciphering anti-colorectal cancer potential of Avicennia alba bioactives via network pharmacology and in vitro validation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-12500-x
|
| 103 |
Giulia Petroni, Giacomo Bagni, Jessica Iorio, Claudia Duranti, Tiziano Lottini, Matteo Stefanini, Goran Kragol, Andrea Becchetti, Annarosa Arcangeli. Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K. Cell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2349-8
|
| 104 |
Xiaolei Gao, Xuan Zheng, Yixin Zhang, Liying Dong, Liangjie Sun, Na Zhao, Chong Ding, Zeyun Ma, Yixiang Wang. Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU via TCF21/CD44 Axis-Mediated Enhanced Stemness in Colorectal Carcinoma. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.788331
|
| 105 |
Khayal Al-Khayal, Mansoor-Ali Vaali-Mohammed, Mohammed Elwatidy, Thamer Bin Traiki, Omar Al-Obeed, Mohammad Azam, Zahid Khan, Maha Abdulla, Rehan Ahmad. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07165-w
|
| 106 |
Fengjing Xu, Zhipeng Wang, Xinhua Song, Mengwei Zhang, Lili Cui, Yanping Liu, Hongxia Yan, Shouhong Gao, Yan Liu, Wansheng Chen, María José Trujillo-Rodríguez. A Direct and Sensitive Method for Determination of 5-Fluorouracil in Colorectal Cancer Cells: Evaluating the Effect of Stromal Cell on Drug Resistance of Cancer Cells. Journal of Analytical Methods in Chemistry 2021; 2021 doi: 10.1155/2021/6689488
|
| 107 |
Joshua D Greenlee, Maria Lopez-Cavestany, Nerymar Ortiz-Otero, Kevin Liu, Tejas Subramanian, Burt Cagir, Michael R King. Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization. eLife 2021; 10 doi: 10.7554/eLife.67750
|
| 108 |
Mateusz Kciuk, Beata Marciniak, Renata Kontek. Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview. International Journal of Molecular Sciences 2020; 21(14) doi: 10.3390/ijms21144919
|
| 109 |
Eloise Clarkson, Annabelle Lewis. BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer. Molecular Oncology 2025; 19(11) doi: 10.1002/1878-0261.70064
|
| 110 |
Mohammad S. El-Wetidy, Rehan Ahmad, Islam Rady, Hamed Helal, Mohamad I. Rady, Mansoor-Ali Vaali-Mohammed, Khayal Al-Khayal, Thamer Bin Traiki, Maha-Hamadien Abdulla. Urolithin A induces cell cycle arrest and apoptosis by inhibiting Bcl-2, increasing p53-p21 proteins and reactive oxygen species production in colorectal cancer cells. Cell Stress and Chaperones 2021; 26(3) doi: 10.1007/s12192-020-01189-8
|
| 111 |
André Fonseca, Sara Ventura Ramalhete, André Mestre, Ricardo Pires das Neves, Ana Marreiros, Pedro Castelo-Branco, Vânia Palma Roberto. Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression. Aging 2021; 13(18) doi: 10.18632/aging.203556
|
| 112 |
Francis Yew Fu Tieng, Nadiah Abu, Siti Nurmi Nasir, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics 2021; 11(11) doi: 10.3390/diagnostics11112136
|
| 113 |
Ali Gholamian Moghaddam, Atchimnaidu Siriki, Debajyoti Majumder, Heba E. Elsayed, Hassan Y. Ebrahim, Khalid El Sayed, Siva Murru. Pyrazolone Compounds as Promising Anticancer Agents for Colorectal Cancer: Synthesis, Antiproliferative Activity, and Mechanistic Insights. ChemMedChem 2026; 21(7) doi: 10.1002/cmdc.202500864
|
| 114 |
Qinxia Chang, Wenting Cheng, Hailong Tian, Siyuan Qin, Yaying Zhang, Jing Zuo, Wenbing Pu, Shuaijun Lu, Na Xie. Zinc‐Coordination‐Driven Pyroptosis Nano‐Inductor Sensitizes Colorectal Cancer Chemo‐Immunotherapy by Specific Delivery and Cell Stemness Suppression. MedComm – Oncology 2026; 5(2) doi: 10.1002/mog2.70075
|
| 115 |
Stephen J. O’Brien, Theodore Kalbfleisch, Sudhir Srivastava, Jianmin Pan, Shesh Rai, Robert E. Petras, Nemencio Ronquillo, Hiram C. Polk, Susan Galandiuk. Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma. Diseases of the Colon & Rectum 2021; 64(9) doi: 10.1097/DCR.0000000000002071
|
| 116 |
Ewelina Piktel, Karolina H Markiewicz, Agnieszka Z Wilczewska, Tamara Daniluk, Sylwia Chmielewska, Katarzyna Niemirowicz-Laskowska, Joanna Mystkowska, Paulina Paprocka, Paul B Savage, Robert Bucki. <p>Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells</p>. International Journal of Nanomedicine 2020; doi: 10.2147/IJN.S255170
|
| 117 |
Chengyao Guo, Jinbo Liu, Quanbo Zhou, Junmin Song, Zhiyong Zhang, Zhen Li, Guixian Wang, Weitang Yuan, Zhenqiang Sun. Exosomal Noncoding RNAs and Tumor Drug Resistance. Cancer Research 2020; 80(20) doi: 10.1158/0008-5472.CAN-20-0032
|
| 118 |
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, Golnaz Goodarzi, Tooba Yousefi, Mahmood Maniati, Mortaza Taheri‐Anganeh, Amir Anushiravani. The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Medical Oncology 2023; 40(4) doi: 10.1007/s12032-023-01980-4
|
| 119 |
Valentina Noemi Madia, Alice Nicolai, Antonella Messore, Alessandro De Leo, Davide Ialongo, Valeria Tudino, Francesco Saccoliti, Daniela De Vita, Luigi Scipione, Marco Artico, Samanta Taurone, Ludovica Taglieri, Roberto Di Santo, Susanna Scarpa, Roberta Costi. Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents. Molecules 2021; 26(3) doi: 10.3390/molecules26030771
|
| 120 |
Jinfang Xue, Xiran Lou, Deyuan Ning, Ruifei Shao, Guobing Chen. Mechanism and treatment of α-amanitin poisoning. Archives of Toxicology 2023; 97(1) doi: 10.1007/s00204-022-03396-x
|
| 121 |
Yuanyuan Shi, Hua Zhu, Hang Jiang, Hongqin Yue, Fang Yuan, Fusheng Wang. Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer. Anti-Cancer Drugs 2023; 34(3) doi: 10.1097/CAD.0000000000001445
|
| 122 |
Salyoc Tapia-Rojas, José Amiel-Pérez, Alejandro Fukusaki-Yoshizawa, Obert Marín-Sánchez, Ana Mayanga-Herrera. The chloroform fraction of Dracontium spruceanum modulates gene expression in gastric cancer stem cells. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-15172-9
|
| 123 |
Yini Xu, Jingpeng Hao, Qiang Chen, Yafei Qin, Hong Qin, Shaohua Ren, Chenglu Sun, Yanglin Zhu, Bo Shao, Jingyi Zhang, Hao Wang. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer. Molecular Carcinogenesis 2024; 63(2) doi: 10.1002/mc.23647
|
| 124 |
Mengmeng Wang, Xuqin Guo, Man Yang, Yawen Zhang, Fanyi Meng, Yinshuang Chen, Mengxi Chen, Tian Qiu, Jiawei Li, Zhi Li, Qi Zhang, Fang Xu, Haiyang Zhang, Weipeng Wang. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3. Biochemical Pharmacology 2022; 199 doi: 10.1016/j.bcp.2022.115025
|
| 125 |
Deyuan Ning, Jinfang Xue, Xiran Lou, Ruifei Shao, Yu Liu, Guobing Chen. Transforming toxins into treatments: the revolutionary role of α-amanitin in cancer therapy. Archives of Toxicology 2024; 98(6) doi: 10.1007/s00204-024-03727-0
|
| 126 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. WEE1 Inhibition by AZD1775 Augments Colorectal Cancer Cells
Susceptibility to VE-822-induced DNA Damage and Apoptosis. Drug Research 2025; 75(02) doi: 10.1055/a-2499-3067
|
| 127 |
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review. International Immunopharmacology 2024; 143 doi: 10.1016/j.intimp.2024.113325
|
| 128 |
Jiyan Haji, Mayada Ilias. Mesenchymal and Vascular Dissemination Markers, Erythroblastosis Virus E26 Oncogene Homolog (ERG) and Alpha Smooth Muscle Actin (α-SMA), in Colorectal Cancer and Adjacent Tissue, Pericytes or Microvascular Density. Cureus 2023; doi: 10.7759/cureus.50059
|
| 129 |
Mei Sun, Xingxiu Chen, Zhibo Yang. Single cell mass spectrometry studies reveal metabolomic features and potential mechanisms of drug-resistant cancer cell lines. Analytica Chimica Acta 2022; 1206 doi: 10.1016/j.aca.2022.339761
|
| 130 |
Amit K. Maiti. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; doi: 10.1007/978-981-16-5422-0_146
|
| 131 |
Erik T. Goka, Marc E. Lippman. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. 2020; doi: 10.1016/B978-0-12-819937-4.00009-1
|
| 132 |
Reem Mebed , Yasser BM Ali, Nahla Shehata, Nahla Gamal, Nadia El-Guendy, Abdel-Rahman Zekri, Salwa Sabet. Combining Bevacizumab with Knocked-Down β-Catenin Reduces
VEGF-A and Slug mRNA in HepG2 but not in Caco-2 Cell Lines. Current Molecular Medicine 2022; 22(4) doi: 10.2174/1573405617666210824120618
|
| 133 |
Lanfang Wu, Jiali Wu, Xinyu Wang, Youfa Xu, Zhizhe Lin, Jianming Chen, Xin Wu. Natural product-based nanotechnological formulations for colorectal cancer treatment. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(10) doi: 10.1007/s00210-025-04175-y
|
| 134 |
Jiaying Li, Jingsen Lv, Yuan Chen, Li Li. Tumor suppressor circPDE4D inhibits the progression of colorectal cancer and regulates oxaliplatin chemoresistance. Gene 2023; 864 doi: 10.1016/j.gene.2023.147323
|
| 135 |
Murdani Abdullah, Budiman Bela, Ari Fahrial Syam, Marcellus Simadibrata, Sofy Meilany, Firda Annisa, Dian Amirulloh, Dadang Makmun, Abdul Aziz Rani. Characterization of colon cancer cells from a patient at Ciptomangun Kusumo National Hospital using CD44, NANOG and OCT4 gene. PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON BIOSCIENCES AND MEDICAL ENGINEERING (ICBME2019): Towards innovative research and cross-disciplinary collaborations 2019; 2155 doi: 10.1063/1.5125545
|
| 136 |
Se-Hee Kim, Sangtae Choi, Won-Suk Lee. Bevacizumab and anexelekto inhibitor, TP-0903 inhibits TGF-β1-induced epithelial–mesenchymal transition of colon cancer cells. Anti-Cancer Drugs 2022; 33(1) doi: 10.1097/CAD.0000000000001239
|
| 137 |
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, Varghese Inchakalody, Shahab Uddin, Alaaeldin Shablak, Said Dermime. The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update. Seminars in Cancer Biology 2023; 89 doi: 10.1016/j.semcancer.2023.01.001
|
| 138 |
Yaya Qiao, Meng Su, Huifang Zhao, Huanle Liu, Chenxi Wang, Xintong Dai, Lingling Liu, Guangju Liu, Huanran Sun, Mingming Sun, Jiyan Wang, Zhen Li, Jun Fan, Quan Zhang, Chunshen Li, Fangmin Situ, Jun Xue, Zhenghu Jia, Chunze Zhang, Shuai Zhang, Changliang Shan. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03032-9
|
| 139 |
Sihan Ke, Zixia Chen, Yutong Qi, Jiantang Zhang, Qizhu Chen, Jun Chen, Huaben Bo.
Heyndrickxia coagulans as a next-generation probiotic: current evidence and future perspectives. Food & Function 2026; 17(1) doi: 10.1039/D5FO03559G
|
| 140 |
Samantha Sharma, Naresh Singh, Anita Ahmed Turk, Isabella Wan, Akshay Guttikonda, Julia Lily Dong, Xinna Zhang, Mateusz Opyrchal. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions. World Journal of Gastroenterology 2024; 30(13): 1815-1835 doi: 10.3748/wjg.v30.i13.1815
|
| 141 |
Ludovic Bretin, David Yannick Leger, Aline Pinon, Soukaina Bouramtane, Frédérique Bregier, Vincent Sol, Vincent Chaleix, Bertrand Liagre, Tayyaba Hasan. Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in a human colorectal cancer in vivo model. 17th International Photodynamic Association World Congress 2019; doi: 10.1117/12.2525033
|
| 142 |
Hoda Deli, Zeynab Vakili-Ghartavol, Yazdan Asgari, Gholamreza Tavoosidana, Ebrahim Eftekhar, Mohammad Hossein Ghahremani. The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-024-13392-2
|
| 143 |
Zhu Li, Gangling Tong, Xiaodan Peng, Shubin Wang. Circ_0005785 Silencing Constrains the Functional Properties of Colorectal Cancer Cells Depending on miR-7-5p/DNMT3A Axis. Biochemical Genetics 2024; 62(3) doi: 10.1007/s10528-023-10522-6
|
| 144 |
Wai-Hung Leung, Jing-Wen Shih, Jian-Syun Chen, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022; 10(2) doi: 10.3390/biomedicines10020377
|
| 145 |
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World Journal of Gastrointestinal Oncology 2020; 12(9): 942-956 doi: 10.4251/wjgo.v12.i9.942
|
| 146 |
Ian T. Saunders, Hina Mir, Neeraj Kapur, Shailesh Singh. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0820-3
|
| 147 |
Sobia Hassan, Talat Mirza, Ambrina Khatoon, Uzma Bukhari, Fouzia Shaikh, Asad Karim. BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12925-z
|
| 148 |
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, Mohammad A. S. Abourehab, Abdus Samad, Walid M. I. Hassan, Rahat Alam, Osman I. Osman, Suza Mohammad Nur, Mohammad Habibur Rahman Molla, Abdulrasheed O. Abdulrahman, Sultana Rajia, Foysal Ahammad, Md Nazmul Hasan, Ishtiaq Qadri, Bonglee Kim. Computational Identification of Druggable Bioactive Compounds from Catharanthus roseus and Avicennia marina against Colorectal Cancer by Targeting Thymidylate Synthase. Molecules 2022; 27(7) doi: 10.3390/molecules27072089
|
| 149 |
Divya Bharti Rai, Kanakaraju Medicherla, Deep Pooja, Hitesh Kulhari. Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment. Pharmaceutics 2023; 15(3) doi: 10.3390/pharmaceutics15030801
|
| 150 |
Sara Moreno-SanJuan, Jose D. Puentes-Pardo, Jorge Casado, Julia Escudero-Feliu, Huda Khaldy, Javier Arnedo, Ángel Carazo, Josefa León. Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer. Antioxidants 2023; 12(4) doi: 10.3390/antiox12040926
|
| 151 |
Eun Joo Jung, Hye Jung Kim, Sung Chul Shin, Gon Sup Kim, Jin-Myung Jung, Soon Chan Hong, Choong Won Kim, Won Sup Lee. β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms24129867
|
| 152 |
Hong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, Wyatt Paulishak, Laurence M. Wood. Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer. Cancers 2023; 15(4) doi: 10.3390/cancers15041237
|
| 153 |
Hiranmoy Bhattacharya, Pratik Chakraborty, Subhajit Kandar, Asis Bala, Saikat Dewanjee. Nanoparticle-based strategies as emerging tools for oral chemotherapy of colorectal cancer. 3 Biotech 2026; 16(6) doi: 10.1007/s13205-026-04846-4
|
| 154 |
Hanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, Lu Zhang, Tao Yu, Yifan Sun, Yujing Li, Changlin Wan, Ka Man So, Degang Liu, Michael Frieden, Yuanzhang Fang, Amber L. Mosley, Xiaoming He, Xinna Zhang, George E. Sandusky, Yunlong Liu, Samy O. Meroueh, Chi Zhang, Aruna B. Wijeratne, Cheng Huang, Guang Ji, Xiongbin Lu. Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation. Journal of Clinical Investigation 2021; 131(10) doi: 10.1172/JCI146832
|
| 155 |
Shibnath Ghatak, Vincent C. Hascall, Roger R. Markwald, Suniti Misra. Hyaluronan. Biology of Extracellular Matrix 2023; 14 doi: 10.1007/978-3-031-30300-5_7
|
| 156 |
Mai A.E. Mourad, Ahmed A.E. Mourad, Ayman Abo Elmaaty, Amal Hofni, Ahmed E. Khodir, Esam M. Aboubakr, Wagdy M. Eldehna, Ahmed A. Al-Karmalawy. Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids. Bioorganic Chemistry 2025; 157 doi: 10.1016/j.bioorg.2025.108285
|
| 157 |
Mahmuda Akter, A. K. M. Atique Ullah, Subrata Banik, Md. Tajuddin Sikder, Toshiyuki Hosokawa, Takeshi Saito, Masaaki Kurasaki. Green Synthesized Silver Nanoparticles-Mediated Cytotoxic Effect in Colorectal Cancer Cells: NF-κB Signal Induced Apoptosis Through Autophagy. Biological Trace Element Research 2021; 199(9) doi: 10.1007/s12011-020-02463-7
|
| 158 |
Xiaoyu Tao, Hongru Wang, Qun Wang, Chengji Wang, Chang-Wei Shao, Yang Jin, Dianping Yu, Hongmei Hu, Qing Zhang, Mengting Xu, Xiangxin Geng, Hanchi Xu, Linyang Li, Ruling Shen, Yue-Wei Guo, Xu-Wen Li, Sanhong Liu, Weidong Zhang. Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1. Journal of the American Chemical Society 2025; 147(41) doi: 10.1021/jacs.5c07917
|
| 159 |
A Palko-Łabuz, E Kostrzewa-Susłow, T Janeczko, K Środa-Pomianek, A Poła, A Uryga, K Michalak. Cyclization of flavokawain B reduces its activity against human colon cancer cells. Human & Experimental Toxicology 2020; 39(3) doi: 10.1177/0960327119882986
|
| 160 |
Alessia Garufi, Giuseppa Pistritto, Valerio D’Orazi, Mara Cirone, Gabriella D’Orazi. The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study. Biomolecules 2022; 12(3) doi: 10.3390/biom12030461
|
| 161 |
Ushasri Chilakamarthi, Namita S. Mahadik, Devulapally Koteshwar, Narra Vamsi Krishna, Lingamallu Giribabu, Rajkumar Banerjee. Potentiation of novel porphyrin based photodynamic therapy against colon cancer with low dose doxorubicin and elucidating the molecular signalling pathways responsible for relapse. Journal of Photochemistry and Photobiology B: Biology 2023; 238 doi: 10.1016/j.jphotobiol.2022.112625
|
| 162 |
Usama A. Fahmy, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, Nabil A. Alhakamy, Helal H. Alsulimani, Filippo Caraci, Giuseppe Caruso. The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells. Pharmaceutics 2020; 12(10) doi: 10.3390/pharmaceutics12100956
|
| 163 |
Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, Karine Breckpot, Kevin Van der Jeught. Colorectal Cancer Immunotherapy: State of the Art and Future Directions. Gastro Hep Advances 2023; 2(8) doi: 10.1016/j.gastha.2023.09.007
|
| 164 |
Omid Cheraghi, Bahareh Dabirmanesh, Farideh Ghazi, Massoud Amanlou, Mona Atabakhshi-kashi, Yaghoub Fathollahi, Khosro Khajeh. The effect of Nrf2 deletion on the proteomic signature in a human colorectal cancer cell line. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10055-y
|
| 165 |
Zahraa Isam Jameel. Four microRNA gene polymorphisms are associated with Iraqi patients with colorectal cancer. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00521-6
|
| 166 |
Purnima Gogoi, Geetika Kaur, Nikhlesh K Singh. Nanotechnology for colorectal cancer detection and treatment. World Journal of Gastroenterology 2022; 28(46): 6497-6511 doi: 10.3748/wjg.v28.i46.6497
|
| 167 |
Jun Gao, Yi Hou, Xiaorui Yang, Jia Liu, Ying Zhang. Melatonin enhances the sensitivity of colorectal cancer cells to 5‐fluorouracil through the regulation of the miR‐532‐3p/β‐catenin pathway. Environmental Toxicology 2024; 39(1) doi: 10.1002/tox.23978
|
| 168 |
Changshun Yang, Yu Zhang, Shengtao Lin, Yi Liu, Weihua Li. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin. Aging 2021; 13(10) doi: 10.18632/aging.202774
|
| 169 |
V. N. Osipov, A. A. Vartanyan, D. A. Khochenkov, D. V. Gusev, O. V. Fateenkova, D. S. Khachatryan, L. M. Borisova. 3-Hydroxyquinazoline Derivatives, Analogues of Erastin, Induce Ferroptosis in Colorectal Cancer Cells. Russian Journal of Bioorganic Chemistry 2024; 50(5) doi: 10.1134/S10681620240
|
| 170 |
Jianen Gao, Lei Zhu. IKKα kinase silencing increases doxorubicin‐induced apoptosis through regulation of oxidative DNA damage response in colon cancer cells. Chemical Biology & Drug Design 2023; 101(5) doi: 10.1111/cbdd.14191
|
| 171 |
Lu Tang, Hua Tian, Qi Min, Huili You, Mengshuang Yin, Liqiong Yang, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Shuai Deng, Xiaobing Li, Meijuan Chen, Li Gu, Yuhong Sun, Zhangang Xiao, Wanping Li, Jing Shen. Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01854-w
|
| 172 |
Bada Yoon, Rajaghatta N. Suresh, Chakrabhavi Dhananjaya Mohan, Kachigere B. Harsha, C.S. Shivakumara, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Gautam Sethi, Kanchugarakoppal S. Rangappa, Kwang Seok Ahn. Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells. Archives of Biochemistry and Biophysics 2025; 770 doi: 10.1016/j.abb.2025.110476
|
| 173 |
Yingyu Zhou, Xuyang Li, Yuki Morita, Satoshi Hachimura, Takuya Miyakawa, Sachiko Takahashi, Masaru Tanokura. Identification of the Effects of Chondroitin Sulfate on Inhibiting CDKs in Colorectal Cancer Based on Bioinformatic Analysis and Experimental Validation. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.705939
|
| 174 |
Francisco Quiñonero, Cristina Mesas, Mercedes Peña, Laura Cabeza, Gloria Perazzoli, Consolación Melguizo, Raul Ortiz, Jose Prados. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer. Applied Sciences 2023; 13(4) doi: 10.3390/app13042667
|
| 175 |
Heping Zhu, Shilong Ying, Bingluo Zhou, Xinyang Hu, Xiao Liang, Wangyu Li, Dungai Wang, Hongchuan Jin, Yuanjiang Pan. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry 2021; 36(1) doi: 10.1080/14756366.2021.1875458
|
| 176 |
Mark J. Lyons, Carsten Ehrhardt, John J. Walsh. Orellanine: From Fungal Origin to a Potential Future Cancer Treatment. Journal of Natural Products 2023; 86(6) doi: 10.1021/acs.jnatprod.2c01068
|
| 177 |
Dan Lin, Haiyang Zhang, Rui Liu, Ting Deng, Tao Ning, Ming Bai, Yuchong Yang, Kegan Zhu, Junyi Wang, Jingjing Duan, Shaohua Ge, Bei Sun, Guoguang Ying, Yi Ba. iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Molecular Oncology 2021; 15(12) doi: 10.1002/1878-0261.13052
|
| 178 |
Yaoyao Zhu, E Zhang, Huan Gao, Chuangeng Shang, Mengxiong Yin, Mingtao Ma, Yu Liu, Xuanfeng Zhang, Xia Li. Resistomycin Inhibits Wnt/β-Catenin Signaling to Induce the Apoptotic Death of Human Colorectal Cancer Cells. Marine Drugs 2023; 21(12) doi: 10.3390/md21120622
|
| 179 |
JaeJin An, Eun-Mi Ha. Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression. Journal of Microbiology 2020; 58(11) doi: 10.1007/s12275-020-0375-y
|
| 180 |
Wei Xin, Yong Zhang. Curcumin activates the JNK signaling pathway to promote ferroptosis in colon cancer cells. Chemical Biology & Drug Design 2024; 103(3) doi: 10.1111/cbdd.14468
|
| 181 |
Lin Huan, Tianan Guo, Yangjun Wu, Linguo Xu, Shenglin Huang, Ye Xu, Linhui Liang, Xianghuo He. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-019-1122-z
|
| 182 |
Yu-Ling Qu, Xiao-Li Liu, Shan-Yu Zhao, Xue-Feng Zhai. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer. Pathology - Research and Practice 2022; 234 doi: 10.1016/j.prp.2022.153895
|
| 183 |
Rita Sala, Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, Laura A. Pike, Qiong Zhou, Wells A. Messersmith, Daniel V. LaBarbera. CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252313160
|
| 184 |
Jeevitha Priya Manoharan, Neha Saravanakumar, Hema Palanisamy, Subramanian Vidyalakshmi. Identification of key players in drug resistant colon cancer - An integrative network pharmacology approach. Human Gene 2026; 47 doi: 10.1016/j.humgen.2025.201521
|
| 185 |
Hussein Al-Akhrass, Niki Christou. The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer. Cancers 2021; 13(12) doi: 10.3390/cancers13122916
|
| 186 |
Farzaneh Ghadiri Moghaddam, Safar Farajnia, Mohammad Karbalaei-Mahdi, Laleh Monir. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review. Molecular Biology Reports 2022; 49(10) doi: 10.1007/s11033-022-07569-w
|
| 187 |
Bashir A. Yousef, Hozeifa M. Hassan, Muhanad Elhafiz, Luyong Zhang, Zhenzhou Jiang. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cells. Synergy 2020; 11 doi: 10.1016/j.synres.2020.100068
|
| 188 |
Meng Deng, Peijie Yan, Hui Gong, Guiqiu Li, Jianjie Wang. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00864-1
|
| 189 |
Hossein Maghsoudi, Motahareh Rasoulzadeh, Maryam Abbastabar, Ahmad Fazilat, Farhad Sheikhnia, Bita Azizzadeh, Mohamad Valilo, Maryam Majidinia. The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03951-3
|
| 190 |
Mehran Molavand, Maryam Majidinia, Bahman Yousefi. Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update. IUBMB Life 2025; 77(11) doi: 10.1002/iub.70074
|
| 191 |
Shu-Ting Hong, Huaching Lin, Chen-Shen Wang, Chih-Hsien Chang, Anya Maan-Yuh Lin, James Chih-Hsin Yang, Yu-Li Lo. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides. Journal of Nanobiotechnology 2019; 17(1) doi: 10.1186/s12951-019-0519-6
|
| 192 |
Satya Narayan, Asif Raza, Iqbal Mahmud, Nayeong Koo, Timothy J. Garrett, Mary E. Law, Brian K. Law, Arun K. Sharma. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience 2022; 25(7) doi: 10.1016/j.isci.2022.104518
|
| 193 |
Mai M. Khalaf, Fardous F. El-Senduny, Hany M. Abd El-Lateef, Hany Elsawy, Ahmed H. Tantawy, Saad Shaaban. Crystalline Gold nanoparticles adjusted by carboxymethyl cellulose and citrate salt: Fabrication, characterization, and in vitro anticancer activity. Journal of Molecular Liquids 2021; 340 doi: 10.1016/j.molliq.2021.117202
|
| 194 |
Xin Qi, Rui Wang, Yuxin Lin, Donghui Yan, Jiachen Zuo, Jiajia Chen, Bairong Shen. A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.692426
|
| 195 |
Vimi Kshetrimayum, Rameshwari Heisnam, Ojit Singh Keithellakpam, Pullapanthula Radhakrishnanand, Sai Jyothi Akula, Pulok K. Mukherjee, Nanaocha Sharma. Paris polyphylla Sm. Induces Reactive Oxygen Species and Caspase 3-Mediated Apoptosis in Colorectal Cancer Cells In Vitro and Potentiates the Therapeutic Significance of Fluorouracil and Cisplatin. Plants 2023; 12(7) doi: 10.3390/plants12071446
|
| 196 |
Ruiyun Wu, Qian Shen, Pinglan Li, Nan Shang. Sturgeon Chondroitin Sulfate Restores the Balance of Gut Microbiota in Colorectal Cancer Bearing Mice. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073723
|
| 197 |
Amit K. Maiti. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2021; doi: 10.1007/978-981-16-1247-3_146-1
|
| 198 |
Yi Jer Tan, Yeuan Ting Lee, Ricardo L. Mancera, Chern Ein Oon. BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells. Life Sciences 2021; 284 doi: 10.1016/j.lfs.2021.119747
|
| 199 |
Annamaria Antona, Marco Varalda, Konkonika Roy, Francesco Favero, Eleonora Mazzucco, Miriam Zuccalà, Giovanni Leo, Giulia Soggia, Valentina Bettio, Martina Tosi, Miriam Gaggianesi, Beatrice Riva, Simone Reano, Armando Genazzani, Marcello Manfredi, Giorgio Stassi, Davide Corà, Sandra D’Alfonso, Daniela Capello. Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer. Cancers 2022; 14(3) doi: 10.3390/cancers14030776
|
| 200 |
Tetsuro Kawagoe, Go Ikeda, Yu Oshiro, Yuta Maruki, Keiko Kaneko, Katsuhiko Iwakiri. Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer. Case Reports in Oncological Medicine 2020; 2020 doi: 10.1155/2020/2351810
|
| 201 |
Yongguo Huang, Hong Sun, Xiang Ma, Ye Zeng, Yang Pan, Dongyang Yu, Zhisheng Liu, Yun Xiang. HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression. Life Sciences 2020; 254 doi: 10.1016/j.lfs.2019.117180
|
| 202 |
Jiawen Bu, Mingming Cui, Yu Zhang, Yu Lu, Xudong Zhu, Fu Peng, Hong Zhang. Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers. MedComm 2025; 6(12) doi: 10.1002/mco2.70513
|
| 203 |
Linsen Zhou, Xinyi Zhang, Zhiqiang Wang, Dongqing Li, Guangjun Zhou, Haofeng Liu. Extracellular vesicle-mediated delivery of miR-766-3p from bone marrow stromal cells as a therapeutic strategy against colorectal cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03493-0
|
| 204 |
Kasun Wanigasooriya, Robert Tyler, Joao D. Barros-Silva, Yashashwi Sinha, Tariq Ismail, Andrew D. Beggs. Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors. Cancers 2020; 12(5) doi: 10.3390/cancers12051278
|
| 205 |
Tatyana Grigoreva, Aleksandra Sagaidak, Angelina Romanova, Daria Novikova, Aleksander Garabadzhiu, Viacheslav Tribulovich. Establishment of drug-resistant cell lines under the treatment with chemicals acting through different mechanisms. Chemico-Biological Interactions 2021; 344 doi: 10.1016/j.cbi.2021.109510
|
| 206 |
Ying Zhang, Changjun Yin, Chao Wei, Shuai Xia, Zhu Qiao, Xue-Wen Zhang, Bin Yu, Jun Zhou, Rong Wang. Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway. Pharmacological Research 2022; 186 doi: 10.1016/j.phrs.2022.106534
|
| 207 |
Barbora Zwinsová, Vyacheslav A. Petrov, Martina Hrivňáková, Stanislav Smatana, Lenka Micenková, Natálie Kazdová, Vlad Popovici, Roman Hrstka, Roman Šefr, Beatrix Bencsiková, Lenka Zdražilová-Dubská, Veronika Brychtová, Rudolf Nenutil, Petra Vídeňská, Eva Budinská. Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression. Cancers 2021; 13(19) doi: 10.3390/cancers13194799
|
| 208 |
Bin Ma, Simeng Bao, Yongmin Li. Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1145753
|
| 209 |
Bahador Mirrahimi, Pejman Rohani, Omid Moradi, Azin Hemmati. Octreotide Efficacy and Safety in Pediatric Non-variceal Upper Gastrointestinal Bleeding: A Randomized Placebo-Controlled Clinical Trial. Iranian Journal of Pediatrics 2022; 32(2) doi: 10.5812/ijp.122344
|
| 210 |
Thanigaivel Shanmugam, Nitin Joshi, Nadim Ahamad, Atul Deshmukh, Rinti Banerjee. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer. International Journal of Pharmaceutics 2020; 586 doi: 10.1016/j.ijpharm.2020.119482
|
| 211 |
Chaobin Li, Kemei Lu, Chenggang Yang, Wenfeng Du, Zhengkai Liang. EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1. Journal of Clinical Laboratory Analysis 2023; 37(2) doi: 10.1002/jcla.24825
|
| 212 |
Peng-Cheng Yu, Di Liu, Zeng-Xiang Han, Fang Liang, Cui-Yun Hao, Yun-Tao Lei, Chang-Run Guo, Wen-Hui Wang, Xing-Hua Li, Xiao-Na Yang, Chang-Zhu Li, Ye Yu, Ying-Zhe Fan. Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.779715
|
| 213 |
Lin Zhao, Hong Chen, QingYi Zhang, Jin Ma, Hao Hu, Lu Xu. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy. Cancer Chemotherapy and Pharmacology 2022; 89(5) doi: 10.1007/s00280-021-04393-0
|
| 214 |
Chunming Li, Xinna Du, Hu Zhang, Shuang Liu. Knockdown of ribosomal protein L22-like 1 arrests the cell cycle and promotes apoptosis in colorectal cancer. Cytojournal 2024; 21 doi: 10.25259/Cytojournal_29_2024
|
| 215 |
Ryia Illani Mohd Yunos, Nurul Syakima Ab Mutalib, Francis Yew Fu Tieng, Nadiah Abu, Rahman Jamal. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine. Biomolecules 2020; 10(3) doi: 10.3390/biom10030476
|
| 216 |
Yuehan Ren, Yun Li, Weiguang Zhang, Kai Yang, Jinlei Li, Yiwang Hu, Zhigui Zuo, Chang Xu, Yifei Pan, Xiaodong Zhang. Mir-4746 inhibits the proliferation of colorectal cancer cells in vitro and in vivo by targeting CCND1. Biochemical and Biophysical Research Communications 2022; 594 doi: 10.1016/j.bbrc.2022.01.063
|
| 217 |
Yousra A. Hagyousif, Ruba A. Zenati, Nelson C. Soares, Hamza M. Al-Hroub, Farman Matloob Khan, Rizwan Qaisar, Rifat Hamoudi, Raafat El-Awady, Ahmad Y. Abuhelwa, Wafaa Ramadan, Waseem El-Huneidi, Eman Abu-Gharbieh, Karem H. Alzoubi, Yasser Bustanji, Mohammad H. Semreen. Molecular signatures of xenograft colorectal cancer in mice treated with topotecan: A mass spectrometry-based study. Toxicology Reports 2025; 14 doi: 10.1016/j.toxrep.2025.102045
|
| 218 |
Alisa S. Postovalova, Vladislava A. Rusakova, Darya R. Akhmetova, Yulia A. Tishchenko, Dmitry S. Sysoev, Mikhail A. Nadporojskii, Konstantin S. Sivak, Sergei A. Shipilovskikh, Alexander S. Timin. Development of 223Ra-labeled polymeric nanocarriers with variable administration routes for alpha-therapy of colorectal cancer. Drug Delivery and Translational Research 2026; 16(1) doi: 10.1007/s13346-025-01900-1
|
| 219 |
Yueli Zhang, Xinchun Wang, Shuyun Wang, Jia Liu, Ruijia Li, Xiaoxia Li, Rui Zhang. Circ‐ERBB2 knockdown sensitized colorectal cancer cells to 5‐FU via miR‐181a‐5p/PTEN/Akt pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(4) doi: 10.1002/jbt.23297
|
| 220 |
Abolfazl Akbari, Maryam Adabi, Mohsen Masoodi, Abolfazl Namazi, Fatemeh Mansouri, Seidamir Pasha Tabaeian, Zahra Shokati Eshkiki. Artificial intelligence: clinical applications and future advancement in gastrointestinal cancers. Frontiers in Artificial Intelligence 2024; 7 doi: 10.3389/frai.2024.1446693
|
| 221 |
Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee. Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers. Journal of Cancer Research and Clinical Oncology 2022; 148(11) doi: 10.1007/s00432-021-03872-4
|
| 222 |
Hannah Johnson, Amandeep Singh, Asif Raza, Congzhou M. Sha, Jian Wang, Krishne Gowda, Zhihang Shen, Haritha Nair, Chenglong Li, Nikolay V. Dokholyan, Satya Narayan, Arun K. Sharma. Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer. Journal of Medicinal Chemistry 2024; 67(20) doi: 10.1021/acs.jmedchem.4c01077
|
| 223 |
Bartosz Klebowski, Malgorzata Stec, Joanna Depciuch, Adrianna Gałuszka, Anna Pajor-Swierzy, Jarek Baran, Magdalena Parlinska-Wojtan. Gold-Decorated Platinum and Palladium Nanoparticles as Modern Nanocomplexes to Improve the Effectiveness of Simulated Anticancer Proton Therapy. Pharmaceutics 2021; 13(10) doi: 10.3390/pharmaceutics13101726
|
| 224 |
Ingrid Sol Cogno, Pamela Gilardi, Laura Comini, Susana C. Núñez-Montoya, Jose Luis Cabrera, Viviana Alicia Rivarola. Natural photosensitizers in photodynamic therapy: In vitro activity against monolayers and spheroids of human colorectal adenocarcinoma SW480 cells. Photodiagnosis and Photodynamic Therapy 2020; 31 doi: 10.1016/j.pdpdt.2020.101852
|
| 225 |
Cheng-Zhi Huang, Yue Zhou, Qi-Song Tong, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du, Xue-Qing Yao. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials 2022; 290 doi: 10.1016/j.biomaterials.2022.121827
|
| 226 |
Sima Nobari, Razieh Amini, Farid Azizi Jalilian, Rezvan Najafi, Fatemeh Bahreini. Combination of Curcumin and Zerumbone Improves VEGF-A Inhibition in Colorectal Cancer In Vivo and In Vitro Model. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 2023; 93(4) doi: 10.1007/s40011-023-01486-z
|
| 227 |
Hao Zhang, Ye Han, Jiaqi Wang, Chunlin Wang, Zewen Chang, Jun Xiang, Hanqing Hu, Ziming Yuan, Nana Zhang, Yuliuming Wang, Chenkai Zhang, Yunxiao Liu, Chengwei Wu, Jian Ma, Xianli Zhou, Guiyu Wang. Lactylation-stabilized NOL6 promotes colorectal cancer progression via STAMBP-mediated YY1 deubiquitination and c-Myc transcription upregulation. Cell Reports 2026; 45(1) doi: 10.1016/j.celrep.2025.116774
|
| 228 |
Langanani Mbodi, Koena A. Kgomo, Amanda Skepu, Konstantinos N. Syrigos, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00015-9
|
| 229 |
Jingwen Liu, Bin Guo. RNA-based therapeutics for colorectal cancer: Updates and future directions. Pharmacological Research 2020; 152 doi: 10.1016/j.phrs.2019.104550
|
| 230 |
Hongyu Wang, Yawen Yang, Juan Du. Cuproptosis: the mechanisms of copper-induced cell death and its implication in colorectal cancer. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04263-z
|
| 231 |
Vaishali Jain, Puja Sakhuja, Anil Kumar Agarwal, Ravi Sirdeshmukh, Fouzia Siraj, Poonam Gautam. Lymph Node Metastasis in Gastrointestinal Carcinomas: A View from a Proteomics Perspective. Current Oncology 2024; 31(8) doi: 10.3390/curroncol31080333
|
| 232 |
Chen Zhong, Guojuan Wang, Min Guo, Naicheng Zhu, Xiudan Chen, Yuwei Yan, Nanxin Li, Wenyan Yu. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance. Cancer Control 2024; 31 doi: 10.1177/10732748241274196
|
| 233 |
Harikumar Pallathadka, Chou-Yi Hsu, Raed Obaid Saleh, S. Renuka Jyothi, Ashwani Kumar, Alexey Yumashev, Aashna Sinha, Ahmed Hussein Zwamel, Mohammed Abed Jawad, Salim B. Alsaadi. Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC). International Immunopharmacology 2024; 140 doi: 10.1016/j.intimp.2024.112730
|
| 234 |
Beatriz Subtil, Kirti K. Iyer, Dennis Poel, Lotte Bakkerus, Mark A. J. Gorris, Jorge Cuenca Escalona, Koen van den Dries, Alessandra Cambi, Henk M. W. Verheul, I. Jolanda M. de Vries, Daniele V. F. Tauriello. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1105244
|
| 235 |
Timothy Crook, Andrew Gaya, Raymond Page, Sewanti Limaye, Anantbhushan Ranade, Amit Bhatt, Sanket Patil, Prashant Kumar, Darshana Patil, Dadasaheb Akolkar. Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors. Cancer Chemotherapy and Pharmacology 2021; 87(2) doi: 10.1007/s00280-020-04189-8
|
| 236 |
Carolina Nunes da Silva, Lays Fernanda Nunes Dourado, Luciana Maria Silva, Aline Brito de Lima, Maria Elena de Lima, Armando Silva-Cunha, Silvia Ligório Fialho. Pathophysiological Effects of Lycosa erythrognatha Derived Peptide LyeTxI-b on RKO-AS-45-1 Colorectal Carcinoma Cell Line Using the Chicken Chorioallantoic Membrane Model. International Journal of Peptide Research and Therapeutics 2022; 28(1) doi: 10.1007/s10989-021-10349-y
|
| 237 |
Wenlong Du, Xiaoping Yang, Shenfu He, Jia Wang, Yuanxian Guo, Bangguo Kou, Yongjie Jiang, Pan Bian, Bingtai Li, Lanning Yin. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Drug Delivery 2021; 28(1) doi: 10.1080/10717544.2021.1914777
|
| 238 |
Adebisi Adeleke, Amusa S. Adebayo, Kafilat Agbaje, Oluwabukunmi Olajubutu, Simeon K. Adesina. Colorectal Cancer: Therapeutic Approaches and Their Complications. Biomedicines 2025; 13(7) doi: 10.3390/biomedicines13071646
|
| 239 |
Sanaa K. Bardaweel, Baraa Abu Sneineh, Rima Hajjo, Reema Abu Khalaf, Amr Ahmed El-Arabey. DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights. PLOS One 2025; 20(10) doi: 10.1371/journal.pone.0334223
|
| 240 |
David I. Cantor, Harish R. Cheruku, Jack Westacott, Joo-Shik Shin, Abidali Mohamedali, Seong Boem Ahn. Proteomic investigations into resistance in colorectal cancer. Expert Review of Proteomics 2020; 17(1) doi: 10.1080/14789450.2020.1713103
|
| 241 |
Shidong Wang, Chen Qiao, Rui Fang, Shuyue Yang, Guiping Zhao, Si Liu, Peng Li. LncRNA CASC19: a novel oncogene involved in human cancer. Clinical and Translational Oncology 2023; 25(10) doi: 10.1007/s12094-023-03165-x
|
| 242 |
Yan Lv, Yanhua Wang, Zhikai Zhang, Jiarui Bao, Huahua Su. Potentials of long non-coding RNAs as biomarkers of colorectal cancer. Clinical and Translational Oncology 2022; 24(9) doi: 10.1007/s12094-022-02834-7
|
| 243 |
Jia He, Wenhan Wu. Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. Non-coding RNA Research 2023; 8(1) doi: 10.1016/j.ncrna.2022.10.001
|
| 244 |
Raajesh Anand Natarajan, Siva Kaliyamoorthy, Vinoth Boopathy, Jawahar Ramasamy, Ravikumar Sambandam. Proteomics-Guided Discovery and Computational Validation of Stable, Cell-Penetrating Plasma Peptides for Targeted Drug Delivery in Colorectal Cancer. International Journal of Peptide Research and Therapeutics 2026; 32(1) doi: 10.1007/s10989-025-10777-0
|
| 245 |
Hua Zhang, Xiaojin Zhao, Fajun Shang, Huan Sun, Xu Zheng, Jiabin Zhu. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells
via Downregulating NF-κB/COX-2 Signaling Pathways. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(10) doi: 10.2174/1871520621666211103103530
|
| 246 |
Hsin‐Yu Yang, Venkanagouda S. Goudar, Yi‐Chi Hung, Chih‐Hsuan Ouyang, Masturah Bte Mohd Abdul Rashid, Liang‐Yi Juo, Jen‐Kuei Wu, Ya‐Wen Cheng, Po‐Li Wei, Huey‐En Tzeng, Jeng‐Kai Jiang, Edward Kai‐Hua Chow, Chih‐Yung Yang, Chih‐Ming Ho, Yun Yen, Fan‐Gang Tseng. In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal Carcinoma. Advanced Therapeutics 2023; 6(6) doi: 10.1002/adtp.202200298
|
| 247 |
Ko-Chao Lee, Kuen-Lin Wu, Chia-Kung Yen, Shun-Fu Chang, Cheng-Nan Chen, Ying-Chen Lu. Inhibition of NLRP3 by Fermented Quercetin Decreases Resistin-Induced Chemoresistance to 5-Fluorouracil in Human Colorectal Cancer Cells. Pharmaceuticals 2022; 15(7) doi: 10.3390/ph15070798
|
| 248 |
Rajaghatta N. Suresh, Young Yun Jung, Kachigere B. Harsha, Chakrabhavi Dhananjaya Mohan, Kwang Seok Ahn, Kanchugarakoppal S. Rangappa. Isoxazolyl-urea derivative evokes apoptosis and paraptosis by abrogating the Wnt/β-catenin axis in colon cancer cells. Chemico-Biological Interactions 2024; 399 doi: 10.1016/j.cbi.2024.111143
|
| 249 |
Hairong Zhou, Zhenyuan Gao, Xiao Wu, Yaping Wang, Lu Zhang. CSF2 promotes chemoresistance in colorectal cancer by regulating Notch pathway. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02285-w
|
| 250 |
Xiaodian Zhang, Hailong Tian, Yang Chen, Baichuan Liang, Edouard C. Nice, Canhua Huang, Na Xie, Shaojiang Zheng. A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02836-3
|
| 251 |
Yan Su, Hack Sun Choi, Jong Hyun Choi, Hee-Sik Kim, Yong-Suk Jang, Jeong-Woo Seo. 7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic Acid Overcomes Chemoresistance of 5-Fluorouracil by Suppressing the Infiltration of Tumor-Associated Macrophages and Inhibiting the Activation of Cancer Stem Cells in a Colorectal Cancer Xenograft Model. Marine Drugs 2023; 21(2) doi: 10.3390/md21020080
|
| 252 |
Xinyi Wang, Haiyang Zhang, Shengjie Yin, Yuchong Yang, Haiou Yang, Jiayu Yang, Zhengyang Zhou, Shuang Li, Guoguang Ying, Yi Ba. lncRNA‐encoded pep‐AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin. The EMBO Reports 2022; 23(1) doi: 10.15252/embr.202153140
|
| 253 |
Nataliya Pidkovka, Abbes Belkhiri. Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1079041
|
| 254 |
Junjie Nie, Xinwei Liu, Mu Xu, Xiaoxiang Chen, Shangshang Hu, Xinliang Gu, Huiling Sun, Tianyi Gao, Yuqin Pan, Shukui Wang. GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer. Translational Oncology 2024; 49 doi: 10.1016/j.tranon.2024.102097
|
| 255 |
Thabiso Victor Miya, Victoria Belancio, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00016-0
|
| 256 |
María Alejandra Trujillo-López, Cristina Muñoz-Olivos, Miguel Ángel Garduño-Vargas, José Manuel Sánchez-López, Verónica Miroslava Martínez-Ortiz, Beatriz Pérez-Armendáriz, Elie Girgis El-Kassis, Elizabeth Bautista-Rodriguez. Bacillus mojavensis postbiotics: transcriptomic and anticancer effects in colon cancer cells. AMB Express 2026; 16(1) doi: 10.1186/s13568-026-02018-4
|
| 257 |
Mohamed A. Tantawy, Nagla A. El-Sherbeeny, Nawal Helmi, Reem Alazragi, Neveen Salem, Samah M. Elaidy. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study. Molecular and Cellular Biochemistry 2020; 469(1-2) doi: 10.1007/s11010-020-03736-4
|
| 258 |
Abdelsattar M. Omar, Moustafa E. El-Araby, Tamer M. Abdelghany, Martin K. Safo, Mostafa H. Ahmed, Rio Boothello, Bhaumik B Patel, Mohamed S. Abdel-Bakky, Azizah M. Malebari, Hany E.A. Ahmed, Radwan S. Elhaggar. Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress. Bioorganic Chemistry 2020; 101 doi: 10.1016/j.bioorg.2020.103953
|
| 259 |
Claudia W K Wu, Madeleine Reid, Simon Leedham, Rashid N Lui. The emerging era of personalized medicine in advanced colorectal cancer. Journal of Gastroenterology and Hepatology 2022; 37(8) doi: 10.1111/jgh.15937
|
| 260 |
Omid Rahbar Farzam, Sahand Eslami, Ali Jafarizadeh, Sania Ghobadi Alamdari, Reza Dabbaghipour, Shima Alizadeh Nobari, Behzad Baradaran. The significance of exosomal non-coding RNAs (ncRNAs) in the metastasis of colorectal cancer and development of therapy resistance. Gene 2025; 937 doi: 10.1016/j.gene.2024.149141
|
| 261 |
Rafaela Nasser Veiga, Alexandre Luiz Korte de Azevedo, Jaqueline Carvalho de Oliveira, Daniela Fiori Gradia. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer. Journal of Molecular Medicine 2024; 102(4) doi: 10.1007/s00109-024-02431-x
|
| 262 |
Attabak Toofani milani, Mahshid Mohammadian, Roghayeh Paribananaem. Evaluation the Anti-proliferative Effect of NVP-AUY922 in Combination with Thymoquinone in Colorectal Cancer Cell Lines. Journal of Research in Applied and Basic Medical Sciences 2021; 7(3) doi: 10.52547/rabms.7.3.122
|
| 263 |
Xueqing Zhang, Heliang Song, Brandon S.B. Canup, Bo Xiao. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer. Expert Opinion on Drug Delivery 2020; 17(6) doi: 10.1080/17425247.2020.1748005
|
| 264 |
David Zaragoza-Huesca, Maria Carmen Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, Jorge Peña-García, Salvador Espín, Guillermo Ricote, Andrés Nieto, Francisco García-Molina, Vicente Vicente, Maria Luisa Lozano, Alberto Carmona-Bayonas, Victoriano Mulero, Horacio Pérez-Sánchez, Irene Martínez-Martínez. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin. Biomedicine & Pharmacotherapy 2023; 168 doi: 10.1016/j.biopha.2023.115814
|
| 265 |
Junghoon Kim, Seonock Lee, Ruijing Sun, Jungho Kim. Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44+CD133+ Tumor-Initiating Caco-2 Cells In Vitro and In Vivo. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.861045
|
| 266 |
Arshiya Mesbah Mousavi, Mohsen Khorashadizadeh, Asghar Zarban, Elham Chamani. The Effects of High and Low-PAD Score (Based on Phenolic level, Antioxidant level and Diastase activity) Honey on Lactate Dehydrogenase (LDH) Activity Level and Glucose Consumption in 5-Fluorouracil Treated HT-29 Cells: An In Vitro Study. Journal of Translational Medical Research 2025; 32(3) doi: 10.61882/JBUMS.32.3.196
|
| 267 |
Sahar Khateeb, Fahad M. Almutairi, Adel I. Alalawy, Amnah Obidan, Mody Albalawi, Rehab Al-Massabi, Hanan Abdulrahman Sagini, Samah S. Abuzahrah, Eman F. S. Taha. β-Sitosterol Enhances the Anticancer Efficacy of Oxaliplatin in COLO-205 Cells via Apoptosis and Suppression of VEGF-A, NF-κB-p65, and β-Catenin. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262210897
|
| 268 |
Henis Patel, Siddhant Palekar, Akanksha Patel, Ketan Patel. Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer. International Journal of Pharmaceutics 2023; 641 doi: 10.1016/j.ijpharm.2023.123056
|
| 269 |
Haoxiu Sun, Chao Liu, Fang Han, Xiaoyu Lin, Liangyu Cao, Chenxing Liu, Qiuyu Ji, Jinjin Cui, Yuanfei Yao, Bojun Wang, Yuanyu liao, Huan Nie, Yanqiao Zhang, Yu Li. The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells. Cell Death & Differentiation 2023; 30(4) doi: 10.1038/s41418-023-01118-z
|
| 270 |
Faisal M. Athikkavil, Sreekumar U. Aiswarya, Remya Johny, Meghna Sudhesh, Amrutha A. Nisthul, Ravi S. Lankalapalli, Ruby J. Anto, Smitha V. Bava. A potent bioactive fraction against colon cancer from Plectranthus vettiveroides. Exploration of Targeted Anti-tumor Therapy 2023; doi: 10.37349/etat.2023.00131
|
| 271 |
Nadia Ben Jemii, Haifa Tounsi-Kettiti, Hamza Yaiche, Najla Mezghanni, Amira Jaballah Gabteni, Emna Fehri, Chayma Ben Fayala, Sonia Abdelhak, Samir Boubaker. Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02614-3
|
| 272 |
Shuya Lu, Jianhui Gao, Huijie Jia, Yang Li, Yongbin Duan, Fuyang Song, Zhiang Liu, Shuai Ma, Mingyong Wang, Tiesuo Zhao, Jiateng Zhong. PD-1-siRNA Delivered by Attenuated Salmonella Enhances the Antitumor Effect of Chloroquine in Colon Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.707991
|
| 273 |
Xianzhe Yu. Controversial role of γδ T cells in colorectal cancer. American Journal of Cancer Research 2024; 14(4) doi: 10.62347/HWMB1163
|
| 274 |
Hong-Xun Ruan, Yan-Le Fang, Xiao-Ning Qin, Lin Lin. Interleukin-22 promotes cancer stemness and chemotherapy resistance in colorectal cancer <i>via</i> epidermal growth factor receptor/extracellular signal-regulated kinase pathway. World Journal of Gastrointestinal Oncology 2025; 17(8): 108535 doi: 10.4251/wjgo.v17.i8.108535
|
| 275 |
Inês Sousa-Oliveira, Belmiro P.M. Duarte, Jorge F.J. Coelho, Ana C. Fonseca, Francisco Veiga, Angel Concheiro, Carmen Alvarez-Lorenzo, Clare Hoskins, Ana Cláudia Paiva-Santos. Optimizing intravenous solid tumour treatment through active targeting approaches and polymeric micelles engineering: A meta-analysis in mouse models. Journal of Controlled Release 2026; doi: 10.1016/j.jconrel.2026.115103
|
| 276 |
Hanjie Xu, Danya Zhang, Rui Wei, Ying Zhou, Geyang Dai, Jie Li, Yue Sun, Fei Li, Ling Xi. Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response. Cancers 2022; 14(22) doi: 10.3390/cancers14225505
|
| 277 |
Md Sadique Hussain, Amita Joshi Rana, Sumel Ashique, Vikash Jakhmola, Gaurav Gupta. Rosmarinic acid as a targeted modulator of NF-κB signaling in colorectal cancer: A promising adjunct to chemotherapy. World Journal of Clinical Oncology 2025; 16(7): 108086 doi: 10.5306/wjco.v16.i7.108086
|
| 278 |
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, Marc Machaalani, Rashad Nawfal, Gianfranco Bittar, Hisham F. Bahmad, Nizar Bitar. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers 2022; 14(9) doi: 10.3390/cancers14092105
|
| 279 |
Elin Julianti, Ikram Ammar Abrian, Marlia Singgih Wibowo, Muhammad Azhari, Nadya Tsurayya, Fauzia Izzati, Ario Betha Juanssilfero, Asep Bayu, Siti Irma Rahmawati, Masteria Yunovilsa Putra. Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. Marine Drugs 2022; 20(1) doi: 10.3390/md20010067
|
| 280 |
Shirui Huang, Jizhen Li, Shuang Wu, Zhijian Zheng, Cong Wang, Hongyan Li, Lingling Zhao, Xiaodong Zhang, Haishan Huang, Chuanshu Huang, Qipeng Xie. C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis. Oncogene 2023; 42(17) doi: 10.1038/s41388-023-02656-z
|
| 281 |
Constanze Buhrmann, Bastian Popper, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal, Mehdi Shakibaei. Evidence That Calebin A, a Component of Curcuma Longa Suppresses NF-κB Mediated Proliferation, Invasion and Metastasis of Human Colorectal Cancer Induced by TNF-β (Lymphotoxin). Nutrients 2019; 11(12) doi: 10.3390/nu11122904
|
| 282 |
Agnese Po, Anna Citarella, Giuseppina Catanzaro, Zein Mersini Besharat, Sofia Trocchianesi, Francesca Gianno, Claudia Sabato, Marta Moretti, Enrico De Smaele, Alessandra Vacca, Micol Eleonora Fiori, Elisabetta Ferretti. Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70871-9
|
| 283 |
Roghayeh Mahmoudi, Elham Salem, Saedeh Khadempar, Alireza Rastgoo Haghi, Zahra Keshtpour Amlashi, Sahar Saki, Masoumeh Darvishi Talemi, Saeid Afshar. Role of Non-coding RNA as a Biomarker of Response to Therapeutic Agents in Colorectal Cancer. Jentashapir Journal of Cellular and Molecular Biology 2022; 13(1) doi: 10.5812/jjcmb.122461
|
| 284 |
Małgorzata Ryczkowska, Natalia Maciejewska, Mateusz Olszewski, Milena Witkowska, Sławomir Makowiec. Design, synthesis, and biological evaluation of tetrahydroquinolinones and tetrahydroquinolines with anticancer activity. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13867-x
|
| 285 |
Mateus de Almeida Rainho, Andre Luiz Mencalha, Alessandra Alves Thole. Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review. Molecular Biology Reports 2021; 48(11) doi: 10.1007/s11033-021-06809-9
|
| 286 |
Kuei-Yen Tsai, Yu-Jia Chang, Chien-Yu Huang, G. M. Shazzad Hossain Prince, Hsin-An Chen, Precious Takondwa Makondi, Ying-Rou Shen, Po-Li Wei. Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04363-5
|
| 287 |
Elmira Roshani Asl, Yousef Rasmi, Behzad Baradaran. MicroRNA‐124‐3p suppresses PD‐L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling. Journal of Cellular Physiology 2021; 236(10) doi: 10.1002/jcp.30378
|
| 288 |
Hong‐Wei Zhang, Yi Shi, Ji‐Bin Liu, Hui‐Min Wang, Pei‐Yao Wang, Zhi‐Jun Wu, Liu Li, Li‐Peng Gu, Ping‐Sheng Cao, Gao‐Ren Wang, Yu‐Shui Ma, Da Fu. Cancer‐associated fibroblast‐derived exosomal microRNA‐24‐3p enhances colon cancer cell resistance to MTX by down‐regulating CDX2/HEPH axis. Journal of Cellular and Molecular Medicine 2021; 25(8) doi: 10.1111/jcmm.15765
|
| 289 |
Weizhen Huang, Hang Zhang, Yunming Tian, Yi Li, Jun Li, Xiaohua Zhong, Xia Yuan. LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p/ABCC1 axis. Anti-Cancer Drugs 2022; 33(6) doi: 10.1097/CAD.0000000000001289
|
| 290 |
Rohini Samadarsi, Linus Augustin, Chandan Kumar, Debjani Dutta. In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancer. BMC Chemistry 2022; 16(1) doi: 10.1186/s13065-022-00835-9
|
| 291 |
Saiprasad Gowrikumar, Mark Primeaux, Kristina Pravoverov, Chao Wu, Bryan C. Szeglin, Charles-Etienne Gabriel Sauvé, Ishwor Thapa, Dhundy Bastola, Xi Steven Chen, J. Joshua Smith, Amar B. Singh, Punita Dhawan. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients. Cells 2021; 10(9) doi: 10.3390/cells10092211
|
| 292 |
Rossella Salemi, Silvia Vivarelli, Daria Ricci, Marina Scillato, Maria Santagati, Giuseppe Gattuso, Luca Falzone, Massimo Libra. Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04036-3
|
| 293 |
Mahalakshmi Suresha Biradar, Shachindra L. Nargund, Shankar Thapa. Synthesis and Cytotoxicity Assay of Aniline Substituted Thienopyrimidines for Anti-Colorectal Cancer Activity. Results in Chemistry 2023; 5 doi: 10.1016/j.rechem.2023.100926
|
| 294 |
Li-qing Zhu, Li Zhang, Jia Zhang, Guo-lin Chang, Gang Liu, Dan-dan Yu, Xiao-min Yu, Mi-sheng Zhao, Bin Ye. Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota. Journal of Integrative Medicine 2021; 19(1) doi: 10.1016/j.joim.2020.11.001
|
| 295 |
Tianqi Liu, Yining Liu, Xiangqian Su, Lin Peng, Jiangbo Chen, Pu Xing, Xiaowen Qiao, Zaozao Wang, Jiabo Di, Min Zhao, Beihai Jiang, Hong Qu. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Computers in Biology and Medicine 2023; 153 doi: 10.1016/j.compbiomed.2023.106545
|
| 296 |
Lucien Torlot, Anna Jarzab, Johanna Albert, Ágnes Pók-Udvari, Arndt Stahler, Julian Walter Holch, Marco Gerlinger, Volker Heinemann, Frederick Klauschen, Thomas Kirchner, Jörg Kumbrink, Bernhard Küster, Andreas Jung. Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance. Journal of Cancer Research and Clinical Oncology 2023; 149(2) doi: 10.1007/s00432-022-04416-0
|
| 297 |
Thabiso Victor Miya, Talent Chipiti, Lloyd Mabonga, Shakeel Kader, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00004-4
|
| 298 |
Ana Ruivo, Rui Caetano Oliveira, Pedro Silva-Vaz, José Guilherme Tralhão. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives. Gastrointestinal Disorders 2023; 5(4) doi: 10.3390/gidisord5040046
|
| 299 |
Alaa Al Moubarak, Manal El Joumaa, Layal Slika, Digambara Patra, Jamilah Borjac. Curcumin-Polyallyhydrocarbon Nanocapsules Potently Suppress 1,2-Dimethylhydrazine-Induced Colorectal Cancer in Mice by Inhibiting Wnt/β-Catenin Pathway. BioNanoScience 2021; 11(2) doi: 10.1007/s12668-021-00842-5
|
| 300 |
Nasrin Haghighi-Najafabadi, Farzin Roohvand, Mohammad Sadegh Shams Nosrati, Ladan Teimoori-Toolabi, Kayhan Azadmanesh. Oncolytic herpes simplex virus type-1 expressing IL-12 efficiently replicates and kills human colorectal cancer cells. Microbial Pathogenesis 2021; 160 doi: 10.1016/j.micpath.2021.105164
|
| 301 |
Xiaonan Zhang, Ece Akcan, Mario Correia, Natallia Rameika, Snehangshu Kundu, Ivaylo Stoimenov, Veronica Rendo, Anna U. Eriksson, Martin Haraldsson, Daniel Globisch, Tobias Sjöblom. Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity. Biochemical Pharmacology 2022; 203 doi: 10.1016/j.bcp.2022.115184
|
| 302 |
V. N. Osipov, A. A. Vartanyan, D. A. Khochenkov, D. V. Gusev, O. V. Fateenkova, D. S. Khachatryan, L. M. Borisova. 3-hydroxyquinazoline derivatives, analogues of erastin, induce ferroptosis in colorectal cancer cells. Биоорганическая химия 2024; 50(5) doi: 10.31857/S0132342324050033
|
| 303 |
Bhargav N. Waghela, Foram U. Vaidya, Chandramani Pathak. Upregulation of NOX-2 and Nrf-2 Promotes 5-Fluorouracil Resistance of Human Colon Carcinoma (HCT-116) Cells. Biochemistry (Moscow) 2021; 86(3) doi: 10.1134/S0006297921030044
|
| 304 |
Lifang Wang, Hack Sun Choi, Yan Su, Binna Lee, Jae Jun Song, Yong-Suk Jang, Jeong-Woo Seo. 7S,15R-Dihydroxy-16S,17S-Epoxy-Docosapentaenoic Acid, a Novel DHA Epoxy Derivative, Inhibits Colorectal Cancer Stemness through Repolarization of Tumor-Associated Macrophage Functions and the ROS/STAT3 Signaling Pathway. Antioxidants 2021; 10(9) doi: 10.3390/antiox10091459
|
| 305 |
Linfu Chen, Rui Zhao, Zheyu Kang, Zhiqin Cao, Nanhui Liu, Jingjing Shen, Cheng Wang, Feng Pan, Xiao Zhou, Zhuang Liu, Yang Yang, Qian Chen. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. Journal of Controlled Release 2023; 363 doi: 10.1016/j.jconrel.2023.09.028
|
| 306 |
Qianshi Zhang, Zhen Feng, Yongnian Zhang, Shasha Shi, Yu Zhang, Shuangyi Ren, Toshimi Chiba. Identification and Verification of a 17 Immune‐Related Gene Pair Prognostic Signature for Colon Cancer. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6057948
|
| 307 |
Natacha Dencker Trabjerg, Christina Rask, Lars Henrik Jensen, Torben Frøstrup Hansen. Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report. Clinical Case Reports 2019; 7(7) doi: 10.1002/ccr3.2262
|
| 308 |
Davide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone, Valentina Belli, Thomas Mohr, Pietro Paolo Vitiello, Giulia Martini, Luca Poliero, Claudia Cardone, Stefania Napolitano, Vincenzo De Falco, Emilio Francesco Giunta, Vincenza Ciaramella, Carminia della Corte, Giusi Barra, Francesco Selvaggi, Renato Franco, Federica Zito Marino, Antonio Cuomo, Floriana Morgillo, Teresa Troiani, Maria Sibilia, Fortunato Ciardiello, Erika Martinelli. Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype. Medical Oncology 2021; 38(3) doi: 10.1007/s12032-021-01464-3
|
| 309 |
Chaozheng Zhang, Yuening Cao, Yi Zuo, Hongbin Cheng, Changqun Liu, Xila Xia, Bo Ren, Yun Deng, Maolin Wang, Jun Lu. Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1149478
|
| 310 |
Parisa Mohammad-Jafarieh, Çığır Biray Avci, Fereshteh Vaziri Nezamdoust, Reza Rahbarghazi, Asghar Khalilnezhad, Elham Shahriyari, Massoud Vosough. Recapitulation of human 3D colorectal cancer model using smart thermo-responsive hydrogel for monitoring angiogenesis. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04226-1
|
| 311 |
Sara Gomes, Ana Catarina Rodrigues, Valerio Pazienza, Ana Preto. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy. International Journal of Molecular Sciences 2023; 24(6) doi: 10.3390/ijms24065069
|
| 312 |
Pedro Cruz-Nova, Alejandra Ancira-Cortez, Guillermina Ferro-Flores, Blanca Ocampo-García, Brenda Gibbens-Bandala. Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer. Pharmaceutics 2022; 14(5) doi: 10.3390/pharmaceutics14051095
|
| 313 |
Shaista Manzoor, Jibran Sualeh Muhammad, Azzam A. Maghazachi, Qutayba Hamid. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.924290
|
| 314 |
Bei Cheng, Peisheng Xu. Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin. Toxins 2020; 12(9) doi: 10.3390/toxins12090582
|
| 315 |
Chul-Won Yun, Jun-Hee Lee, Gyeongyun Go, Juhee Jeon, Sungtae Yoon, Sang-Hun Lee. Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer. Cancers 2021; 13(9) doi: 10.3390/cancers13092144
|
| 316 |
Mateusz Olszewski, Natalia Maciejewska, Anoop Kallingal, Agnieszka Chylewska, Aleksandra M. Dąbrowska, Małgorzata Biedulska, Mariusz Makowski, José M. Padrón, Maciej Baginski. Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction. Journal of Enzyme Inhibition and Medicinal Chemistry 2024; 39(1) doi: 10.1080/14756366.2024.2302920
|
| 317 |
B. González Astorga, F. Salvà Ballabrera, E. Aranda Aguilar, E. Élez Fernández, P. García-Alfonso, E. González Flores, R. Vera García, A. Fernández Montes, A. M. López Muñoz, A. Salud Salvia. Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept. Clinical and Translational Oncology 2021; 23(8) doi: 10.1007/s12094-021-02568-y
|
| 318 |
Masoumeh Dehghanzad, Mohammad Mohammadi, Mohaddeseh Nejati, Farhad Pouremamali, Nazila Fathi Maroufi, Maryam Akbarzadeh, Naser Samadi, Mohammad Nouri. The potential therapeutic effect of melatonin in oxaliplatin combination therapy against chemoresistant colorectal cancer cells. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09316-9
|
| 319 |
Lei Shen, Kang Hou, Jifeng Zhang, Xiaodong Li. Analysis of the molecular subtypes and prognostic models of anoikis-related genes in colorectal cancer. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1579843
|
| 320 |
Mandy Gruijs, Rens Braster, Marije B. Overdijk, Tessa Hellingman, Sandra Verploegen, Rianne Korthouwer, Berend J. van der Wilk, Paul W. H. I. Parren, Hans J. van der Vliet, Marijn Bögels, Marjolein van Egmond, Yingming Sun. Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells. Journal of Oncology 2022; 2022 doi: 10.1155/2022/3577928
|
| 321 |
Agnes K. Böhm, Lisa M. Skrip, Oliver Klein, Felix Strobl, Jonas K. Wieland, Alexander Arnold, Yijun Zhou, Björn Papke, Christine Sers, Dominik P. Modest, Simon Moosburner, Philipp K. Haber, Felix Krenzien, Nathanael Raschzok, Wenzel Schöning, David Horst, Thomas Malinka, Ingolf Sack, Johann Pratschke, Igor M. Sauer, Karl H. Hillebrandt. Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-026-07945-1
|
| 322 |
Abeer A.A. Salama, Rasha M. Allam. Promising targets of chrysin and daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9. European Journal of Pharmacology 2021; 892 doi: 10.1016/j.ejphar.2020.173763
|
| 323 |
Cecilia Villegas, Rebeca Perez, Olov Sterner, Iván González-Chavarría, Cristian Paz. Curcuma as an adjuvant in colorectal cancer treatment. Life Sciences 2021; 286 doi: 10.1016/j.lfs.2021.120043
|
| 324 |
Roberto de Paula do Nascimento, Julia Soto Rizzato, Gabriele Polezi, Hatim Boughanem, Non Gwenllian Williams, Renata Galhardo Borguini, Manuela Cristina Pessanha de Araujo Santiago, Mario Roberto Marostica Junior, Lee Parry. Myrciaria jaboticaba Fruit Peel: Bioactive Composition as Determined by Distinct Harvest Seasons and In Vitro Anti-Cancer Activity. Plants 2024; 13(20) doi: 10.3390/plants13202907
|
| 325 |
Haiyan Dong, Limei Hu, Weiqian Li, Mengchen Shi, Lingyuan He, Chen Wang, Yijia Hu, Huihui Wang, Chuangyu Wen, Huanliang Liu, Xiangling Yang. Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancer. Molecular Biology Reports 2022; 49(6) doi: 10.1007/s11033-022-07262-y
|
| 326 |
Bo Zhao, Biqi Li, Yongjun Chen, Jisai Chen, Wenjin Chen, Xiaoyong Cai, Wenqi Lu. WITHDRAWN: CDKN2A is a promising diagnostic and prognostic biomarker and associations with immune infiltrates in colorectal cancer. Heliyon 2025; doi: 10.1016/j.heliyon.2025.e43049
|
| 327 |
Ruoyang Chai, Yajie Zhao, Zhengjia Su, Wei Liang. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1277084
|
| 328 |
Cheng-Ann Winston Ng, Amy Aimei Jiang, Emma Min Shuen Toh, Cheng Han Ng, Zhi Hao Ong, Siyu Peng, Hui Yu Tham, Raghav Sundar, Choon Seng Chong, Chin Meng Khoo. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. International Journal of Colorectal Disease 2020; 35(8) doi: 10.1007/s00384-020-03676-x
|
| 329 |
Batoul Abi Zamer, Waseem El-Huneidi, Mohamed Ahmed Eladl, Jibran Sualeh Muhammad. Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives. Cells 2021; 10(11) doi: 10.3390/cells10112862
|
| 330 |
Lu Zhan, Fangting Su, Qiang Li, Yueqiang Wen, Feng Wei, Zhelin He, Xiaoyan Chen, Xiang Yin, Jian Wang, Yilin Cai, Yuxia Gong, Yu Chen, Xiao Ma, Jinhao Zeng. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1257450
|
| 331 |
Kai Wang, De-Zhi Hou, Yi-Ming Ouyang, Ping Ling. Resveratrol enhances paclitaxel-induced apoptosis through oxidative DNA damage in Caco-2 human colon cancer cells. South African Journal of Botany 2023; 157 doi: 10.1016/j.sajb.2023.04.023
|
| 332 |
Sima Nobari, Rezvan Najafi, Ali Mahdavinezhad, Akram jalali, Razieh Amini, Talha Bin Emran. The Combination of Zerumbone with 5-Fluorouracil for Sensitizing Colorectal Cancer-Associated Fibroblasts to Treatment. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/9369328
|
| 333 |
Zheng-Dong Luo, Yi-Feng Wang, Yu-Xiao Zhao, Long-Chen Yu, Tian Li, Ying-Jing Fan, Shun-Jie Zeng, Yan-Li Zhang, Yi Zhang, Xin Zhang. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World Journal of Gastroenterology 2023; 29(1): 1-18 doi: 10.3748/wjg.v29.i1.1
|
| 334 |
Wenxin Deng, Xiaojian Xiong, Mingyang Lu, Shibo Huang, Yunfei Luo, Yujie Wang, Ying Ying. Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12898-z
|
| 335 |
Ashley R. Hoover, Kaili Liu, Trisha I. Valerio, Min Li, Priyabrata Mukherjee, Wei R. Chen. Nano‐ablative immunotherapy for cancer treatment. Nanophotonics 2021; 10(12) doi: 10.1515/nanoph-2021-0171
|
| 336 |
Yagang Mu, Jian Wang, Guang Li. Sphingosine kinase‐2 silencing modulates sensitivity of HT‐29 human colorectal cancer cells to paclitaxel‐induced cell death through altering apoptosis‐related proteins. Chemical Biology & Drug Design 2023; 102(2) doi: 10.1111/cbdd.14232
|
| 337 |
Francisco Quiñonero, Ana Cepero, David Urbano, José A. Muñoz-Gámez, Sandra M. Martín-Guerrero, David Martín-Oliva, Jose Prados, Consolación Melguizo, Raul Ortiz. Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: A preliminary study. Journal of Biosciences 2021; 46(1) doi: 10.1007/s12038-020-00135-1
|
| 338 |
Ruiyun Wu, Nan Shang, Meng Gui, Jian Yin, Pinglan Li. Sturgeon (Acipenser)-Derived Chondroitin Sulfate Suppresses Human Colon Cancer HCT-116 Both In Vitro and In Vivo by Inhibiting Proliferation and Inducing Apoptosis. Nutrients 2020; 12(4) doi: 10.3390/nu12041130
|
| 339 |
Abilasha G. Jayathilake, Margaret F. Veale, Rodney Brain Luwor, Kulmira Nurgali, Xiao Q. Su. Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03160-7
|
| 340 |
Weijia Zhang, Chang Peng, Xue Shen, Yuemei Yuan, Wei Zhang, Chunjuan Yang, Meicun Yao. A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells. Molecules 2021; 26(13) doi: 10.3390/molecules26133843
|
| 341 |
Changfu Liu, Wenge Xing, Haipeng Yu, Weihao Zhang, Tongguo Si. ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01800-7
|
| 342 |
Wei-Kun Shi, Yun-Hao Li, Xue-Shan Bai, Guo-Le Lin. The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.834235
|
| 343 |
Dan Su, Chunye Lv. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway. Bioengineered 2021; 12(2) doi: 10.1080/21655979.2021.2009965
|
| 344 |
Yang Han, Su Lu, Chenlong Song, Yi Xuan, Meng Zhang, Hong Cai. Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01386-1
|
| 345 |
Francis Park-Yun Cheung, Naveed Zeb Alam, Gavin Michael Wright. The Past, Present and Future of Pulmonary Metastasectomy: A Review Article. Annals of Thoracic and Cardiovascular Surgery 2019; 25(3) doi: 10.5761/atcs.ra.18-00229
|
| 346 |
Nahid Rezvani Jalal, Tayyebeh Madrakian, Abbas Afkhami, Arash Ghoorchian. Graphene oxide nanoribbons/polypyrrole nanocomposite film: Controlled release of leucovorin by electrical stimulation. Electrochimica Acta 2021; 370 doi: 10.1016/j.electacta.2021.137806
|
| 347 |
Yitong Li, Zhenmei Chen, Jiahao Han, Xiaochen Ma, Xin Zheng, Jinhong Chen. Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.781233
|
| 348 |
Zhou Tong, Cong Yan, Yu-An Dong, Ming Yao, Hangyu Zhang, Lulu Liu, Yi Zheng, Peng Zhao, Yimin Wang, Weijia Fang, Feifei Zhang, Weiqin Jiang. Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine. BMC Medical Genomics 2020; 13(1) doi: 10.1186/s12920-020-00794-x
|
| 349 |
Fahima Danesh Pouya, Maria Gazouli, Yousef Rasmi, Dimitra Ioanna Lampropoulou, Mohadeseh Nemati. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil. Molecular Biology Reports 2022; 49(6) doi: 10.1007/s11033-022-07227-1
|
| 350 |
Liguo Xie, Lifangyu Cheng, Yunlin Wei. Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer. Pathology - Research and Practice 2023; 243 doi: 10.1016/j.prp.2023.154350
|
| 351 |
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, Afshin Arti, Karim Nayernia, Babak Behnam. Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review. Biomedicines 2024; 12(1) doi: 10.3390/biomedicines12010183
|
| 352 |
Jie Wang, Hao Pan, Jingyi Li, Di Nie, Yan Zhuo, Yishan Lv, Ning Wang, Hao Chen, Shiyan Guo, Yong Gan, Xinggang Yang, Miaorong Yu. Cell membrane-coated mesoporous silica nanorods overcome sequential drug delivery barriers against colorectal cancer. Chinese Chemical Letters 2023; 34(6) doi: 10.1016/j.cclet.2022.107828
|
| 353 |
Xin Guo, Wei Zhou, Jinmei Jin, Jiayi Lin, Weidong Zhang, Lijun Zhang, Xin Luan. Integrative Multi-Omics Analysis Identifies Transmembrane p24 Trafficking Protein 1 (TMED1) as a Potential Prognostic Marker in Colorectal Cancer. Biology 2024; 13(2) doi: 10.3390/biology13020083
|
| 354 |
Xi Lu, Lei Zhong, Emma Lindell, Margus Veanes, Jing Guo, Miao Zhao, Maede Salehi, Fredrik J. Swartling, Xingqi Chen, Tobias Sjöblom, Xiaonan Zhang. Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells. Cell Death & Disease 2023; 14(10) doi: 10.1038/s41419-023-06204-1
|
| 355 |
Sunil Kumar, Pankaj Kumar, Zahid Bashir Zargar, Shubham Debaje, Aashima Batra, Deepak B. Salunke, Abhay T. Sangamawar, Sandip V. Pawar. Unveiling anticancer potential of imidazo-pyridine/pyrazine-fused bicyclic heterocycles: Insights from in silico and in vitro studies. In Silico Research in Biomedicine 2026; 2 doi: 10.1016/j.insi.2026.100177
|
| 356 |
Fatima Dandash, David Y. Leger, Mona Diab-Assaf, Vincent Sol, Bertrand Liagre. Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer. Molecules 2021; 26(23) doi: 10.3390/molecules26237268
|
| 357 |
Yujun Wang, Zhirong Yang, Wanglong Zhu, Yuzhuo Chen, Xingqiang He, Jiaofeng Li, Zhengyu Han, Yuhan Yang, Wei Liu, Kun Zhang. Dihydroartemisinin inhibited stem cell‐like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling. Drug Development Research 2023; 84(5) doi: 10.1002/ddr.22067
|
| 358 |
Xiaohui Wang, Zhiyuan Xu, Jian Wang, Chunrong Wu, Lin Zhang, Chengyuan Qian, Yang Luo, Yanjuan Gu, Wing‐Tak Wong, Debing Xiang. A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction. Advanced Science 2025; 12(13) doi: 10.1002/advs.202410630
|
| 359 |
Min Ji, Yanping Chen, Lu Zhang, Leqian Ying, Chunchun Huang, Lin Liu. Construction and Evaluation of an M2 Macrophage-Related Prognostic Model for Colon Cancer. Applied Biochemistry and Biotechnology 2024; 196(8) doi: 10.1007/s12010-023-04789-z
|
| 360 |
Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel. Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics. Toxins 2021; 13(6) doi: 10.3390/toxins13060417
|
| 361 |
Shiekhah Alzahrani, Huda Al Doghaither, Ayat Al‑ghafari, Peter Pushparaj. 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncology Reports 2023; 50(4) doi: 10.3892/or.2023.8612
|
| 362 |
Liwei Yan, Dandan Wang, Xiaoming Liu, Chao Gu, Shanyu Gao. Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2. Anti-Cancer Drugs 2021; 32(8) doi: 10.1097/CAD.0000000000001080
|
| 363 |
Sandra Ríos-Arrabal, Jose D. Puentes-Pardo, Sara Moreno-SanJuan, Ágata Szuba, Jorge Casado, María García-Costela, Julia Escudero-Feliu, Michela Verbeni, Carlos Cano, Cristina González-Puga, Alicia Martín-Lagos Maldonado, Ángel Carazo, Josefa León. Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53. Journal of Personalized Medicine 2021; 11(6) doi: 10.3390/jpm11060509
|
| 364 |
Xiangnv Meng, Zhongting Lu, Fu Mi, Sha Sha, Tao Li. Research hotspots and emerging trends in targeted therapy for colorectal cancer: a bibliometric analysis (2000–2023). Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02632-x
|
| 365 |
Valentin Benboubker, George M. Ramzy, Sacha Jacobs, Patrycja Nowak-Sliwinska. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03173-x
|
| 366 |
Andong Zhao, Yu Wang, Fuliang Lin, Keyun Bai, Chao Gu. Long noncoding RNA LBX2‐AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression. Journal of Biochemical and Molecular Toxicology 2022; 36(5) doi: 10.1002/jbt.23020
|
| 367 |
Nam Hyun Kim, Seokjoon Lee, Woon‐seob Shin, Sangtae Oh. Effects of phenoxyartemisinin derivatives on the inhibition of colorectal cancer and cancer stem cells. Bulletin of the Korean Chemical Society 2025; 46(8) doi: 10.1002/bkcs.70047
|
| 368 |
Jaskiran Kaur, Monica Gulati, K. Gowthamarajan, Sukriti Vishwas, Dinesh Kumar Chellappan, Gaurav Gupta, Kamal Dua, Narendra Kumar Pandey, Bimlesh Kumar, Sachin Kumar Singh. Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A hypothesis. Medical Hypotheses 2021; 156 doi: 10.1016/j.mehy.2021.110679
|
| 369 |
Neda Khosravi, Vahid Khaze Shahgoli, Mohammad Amini, Sahar Safaei, Ahad Mokhtarzadeh, Behzad Mansoori, Afshin Derakhshani, Amir Baghbanzadeh, Behzad Baradaran. Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil. European Journal of Pharmacology 2021; 894 doi: 10.1016/j.ejphar.2021.173871
|
| 370 |
Mingyang Shen, Zhengyuan Zhang, Ping Wang, Wey-Ran Lin. GLI3 Promotes Invasion and Predicts Poor Prognosis in Colorectal Cancer. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8889986
|
| 371 |
Matas Jakubauskas, Lina Jakubauskiene, Bettina Leber, Angela Horvath, Kestutis Strupas, Philipp Stiegler, Peter Schemmer. Probiotic Supplementation Suppresses Tumor Growth in an Experimental Colorectal Cancer Liver Metastasis Model. International Journal of Molecular Sciences 2022; 23(14) doi: 10.3390/ijms23147674
|
| 372 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09431-7
|
| 373 |
Fei Li, Xu Jiao, Jing Zhao, Xiaojun Liao, Yunlu Wei, Quanhong Li. Antitumor mechanisms of an exopolysaccharide from Lactobacillus fermentum on HT-29 cells and HT-29 tumor-bearing mice. International Journal of Biological Macromolecules 2022; 209 doi: 10.1016/j.ijbiomac.2022.04.023
|
| 374 |
Maryam Hejazi, Elham Baghbani, Mohammad Amini, Tayebeh Rezaei, Ayuob Aghanejad, Jafar Mosafer, Ahad Mokhtarzadeh, Behzad Baradaran. MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer. Journal of Cellular Biochemistry 2020; 121(2) doi: 10.1002/jcb.29374
|
| 375 |
Alireza Hosseini-Abgir, Mohammad mehdi Naghizadeh, Somayeh Igder, Behnoosh Miladpour. Insilco prediction of the role of the FriZZled5 gene in colorectal cancer. Cancer Treatment and Research Communications 2023; 36 doi: 10.1016/j.ctarc.2023.100751
|
| 376 |
Aurelien Mammes, Jennifer Pasquier, Olivier Mammes, Marc Conti, Richard Douard, Sylvain Loric. Extracellular vesicles: General features and usefulness in diagnosis and therapeutic management of colorectal cancer. World Journal of Gastrointestinal Oncology 2021; 13(11): 1561-1598 doi: 10.4251/wjgo.v13.i11.1561
|
| 377 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; doi: 10.1016/B978-0-443-24742-2.00005-8
|
| 378 |
Lloyd Mabonga, Rebecca Leony Fourie, Abidemi Paul Kappo, Sylvester Lyantagaye, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00001-9
|
| 379 |
Chengyuan Xu, Tengfei Li, Lin Zhang, Qin Zhang, Shanshan Cai, Qiangqiang Fu, Siqi Zhang. LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses. Neoplasia 2026; 72 doi: 10.1016/j.neo.2025.101267
|
| 380 |
Selin Cesmeli, Bakiye Goker Bagca, Hasan Onur Caglar, Neslihan Pinar Ozates, Cumhur Gunduz, Cigir Biray Avci. Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs. Medical Oncology 2022; 39(1) doi: 10.1007/s12032-021-01611-w
|
| 381 |
Pei-Qiu Cheng, Yu-Jing Liu, Sheng-An Zhang, Lu Lu, Wen-Jun Zhou, Dan Hu, Han-Chen Xu, Guang Ji. RNA-Seq profiling of circular RNAs in human colorectal cancer 5-fluorouracil resistance and potential biomarkers. World Journal of Gastrointestinal Oncology 2022; 14(3): 678-689 doi: 10.4251/wjgo.v14.i3.678
|
| 382 |
Eluri Pavitra, Begum Dariya, Gowru Srivani, Sung-Min Kang, Afroz Alam, Putty-Reddy Sudhir, Mohammad Amjad Kamal, Ganji Seeta Rama Raju, Young-Kyu Han, Bhaskar Venkata Kameswara Subrahmanya Lakkakula, Ganji Purnachandra Nagaraju, Yun Suk Huh. Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Seminars in Cancer Biology 2021; 69 doi: 10.1016/j.semcancer.2019.06.017
|
| 383 |
Alessia Garufi, Riccardo Pettinari, Fabio Marchetti, Mara Cirone, Gabriella D’Orazi. NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020593
|
| 384 |
Apeksha Saraf, Nidhi Dubey, Nitin Dubey, Mayank Sharma. Enhancement of cytotoxicty of diallyl disulfide toward colon cancer by Eudragit S100/PLGA nanoparticles. Journal of Drug Delivery Science and Technology 2021; 64 doi: 10.1016/j.jddst.2021.102580
|
| 385 |
Águeda Martínez-Barriocanal, Diego Arango, Higinio Dopeso. PVT1 Long Non-coding RNA in Gastrointestinal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00038
|
| 386 |
FEI SHA, DAISHAN XIN, JUN XU, ZHIWEI ZHENG, WENXIN LIN, XIAORUI CAI, FEI LIN, MINGHAO ZHENG, JIAOLING CHEN. Curcumin inhibits colorectal cancer development by blocking the YAP/TAZ signaling axis. BIOCELL 2024; 48(3) doi: 10.32604/biocell.2023.029188
|
| 387 |
Zodwa Dlamini, Rodney Hull, Andreas M. Kaufmann. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00009-3
|
| 388 |
Yiran Tao, Ruixue Wang, Qinhuai Lai, Mengdan Wu, Yuxi Wang, Xiaohua Jiang, Lishi Zeng, Shijie Zhou, Zhongping Li, Tinghan Yang, Yuqin Yao, Yangping Wu, Lin Yu, Yuyin Fu, Weirong Lai, Yujia Peng, Ying Lu, Zhixiong Zhang, Cuiyu Guo, Guangbing Zhang, Lantu Gou, Jinliang Yang. Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma. Molecular Oncology 2019; 13(9) doi: 10.1002/1878-0261.12520
|
| 389 |
Shanshan Lin, Bo Zhu. Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4. Molecular and Cellular Biochemistry 2024; 479(3) doi: 10.1007/s11010-023-04737-9
|
| 390 |
Pedro Henrique Leite Bonfitto. Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets. American Journal of Cancer Research 2024; 14(11) doi: 10.62347/PJNU8987
|
| 391 |
Wen-Yue Liu, Han Wang, Xin Xu, Xuan Wang, Kun-Kun Han, Wen-Dao You, Yili Yang, Tao Zhang. Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling. World Journal of Clinical Oncology 2025; 16(5): 105341 doi: 10.5306/wjco.v16.i5.105341
Abstract(365) |
Core Tip(326) |
Full Article(HTML)(1161)
|
Full Article (PDF)-6999K(137)
|
Full Article with Cover (PDF)-7168K(149)
|
Full Article (XML)-68K(80)
|
Audio-288K(8)
|
Peer-Review Report-228K(78)
|
Answering Reviewers-97K(93)
|
Supplementary Material-50K(62)
|
Times Cited (8)
|
Total Visits (1820)
|
Open
|
| 392 |
Kavita Pandey, Shahid Umar. Microbiome in drug resistance to colon cancer. Current Opinion in Physiology 2021; 23 doi: 10.1016/j.cophys.2021.100472
|
| 393 |
Liang Xiao, Yan Zhu, Haixia Xu, Lin Lin, Meixiang Li, Yayan Zhou. Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153–5p/MYO6 in colorectal cancer. Pathology - Research and Practice 2024; 260 doi: 10.1016/j.prp.2024.155476
|
| 394 |
Binayak Kumar, Deepu Sharma, Jyotsna Gorantala, Sri Krishna Jayadev Magani. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; doi: 10.1007/978-981-15-5471-1_4
|
| 395 |
Maryam Ghanbari-Movahed, Gloria Jackson, Mohammad Hosein Farzaei, Anupam Bishayee. A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.639840
|
| 396 |
Maryam Ghanbari-Movahed, Tea Kaceli, Arijit Mondal, Mohammad Hosein Farzaei, Anupam Bishayee. Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review. Biomedicines 2021; 9(5) doi: 10.3390/biomedicines9050480
|
| 397 |
Ziyang Sun, Siqi Zhang, Lei Zhao, Shuhao Wang, Zhenhua Lin, Aihua Jin. Identification of Epithelial FTL Expression as an Important Predictor for Prognosis of Colon Adenocarcinoma. Journal of Biomaterials and Tissue Engineering 2023; 13(3) doi: 10.1166/jbt.2023.3275
|
| 398 |
Linda Galasso, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Federica Vitale, Alberto Nicoletti, Mattia Paratore, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights. Cancers 2025; 17(3) doi: 10.3390/cancers17030368
|
| 399 |
Qi Zhao, Yan Zhang, Jieyu Liu, Peipei Chen, Annabeth Onga, Namki Cho, Ri Cui, Chenguo Zheng. Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1532695
|
| 400 |
Xiew Leng Liau, Shamala Salvamani, Baskaran Gunasekaran, Dinesh Kumar Chellappan, Anthony Rhodes, Vaidehi Ulaganathan, Yee Lian Tiong. CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer. British Journal of Biomedical Science 2023; 80 doi: 10.3389/bjbs.2023.11103
|
| 401 |
Dan Xia, Bin He, Lijun Li, Wenbin Gao. Freeze-dried curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles restrain colorectal cancer progression by targeting the notch pathway to regulate epithelial-mesenchymal transition. Materials Express 2022; 12(9) doi: 10.1166/mex.2022.2263
|
| 402 |
Emaan Shah, Hager Mesrati, Usama Aldallal, Fatema Abdulwahab, Fryad Henari, Stephen Safrany. Assessing the photodynamic therapeutic effects of 5‑aminolevulinic acid on human colon cancer cells using light‑emitting diodes. World Academy of Sciences Journal 2021; 3(5) doi: 10.3892/wasj.2021.114
|
| 403 |
Anshul Panjeta, Simran Preet. Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: A therapeutic approach. Peptides 2020; 126 doi: 10.1016/j.peptides.2020.170263
|
| 404 |
Haifeng Wang, Weihuo Pan. Challenges of chimeric antigen receptor-T/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies. Molecular and Cellular Biochemistry 2023; 478(5) doi: 10.1007/s11010-022-04568-0
|
| 405 |
Dilşad Özerkan, Ferdane Danışman-Kalındemirtaş, İshak Afşin Kariper. Synthesis and characterization of NIR-sensitive curcumin-gelatin nanoparticles for targeted drug delivery in 3D colon cancer. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-42199-3
|
| 406 |
Francesca Paganelli, Francesca Chiarini, Annalisa Palmieri, Marcella Martinelli, Paola Sena, Jessika Bertacchini, Luca Roncucci, Alessandra Cappellini, Alberto M. Martelli, Massimo Bonucci, Carla Fiorentini, Ivano Hammarberg Ferri. The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine. Pharmaceuticals 2021; 14(12) doi: 10.3390/ph14121325
|
| 407 |
Soghra Bagheri, Ali A. Saboury. Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia. Xenobiotica 2021; 51(7) doi: 10.1080/00498254.2021.1929557
|
| 408 |
Yujun Huang, Jinyong He, Nan Chen, Xiuting Du, Junhui Peng. ETV4 promotes the growth, metastasis, glycolysis, and oxaliplatin resistance of colorectal cancer by transcription activation-mediated SLC38A5 upregulation. Pathology - Research and Practice 2025; 271 doi: 10.1016/j.prp.2025.156033
|
| 409 |
Jiying Lu, Zhekang Jin, Xihan Jin, Wenbin Chen. Prognostic value and potential regulatory relationship of miR‐200c‐5p in colorectal cancer. Journal of Biochemical and Molecular Toxicology 2024; 38(8) doi: 10.1002/jbt.23770
|
| 410 |
Hasan Al-Nasrawi, Naeem Shalan, Bassam M Abualsoud, Hamdi Nsairat.
Preparation, characterization and
in vitro
evaluation of 5-fluorouracil loaded into chitosan–acacia gum nanoparticles
. Therapeutic Delivery 2024; 15(5) doi: 10.4155/tde-2023-0136
|
| 411 |
Pouriya Sameti, Mohammad Amini, Fatemeh Oroojalian, Yalda Baghay Esfandyari, Maryam Tohidast, Seyed Ali Rahmani, Shirin Azarbarzin, Ahad Mokhtarzadeh, Behzad Baradaran. MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers. Molecular Biotechnology 2024; 66(7) doi: 10.1007/s12033-023-00756-5
|
| 412 |
Leonid Kharin, Igor Bychkov, Nikolay Karnaukhov, Mark Voloshin, Rushaniya Fazliyeva, Alexander Deneka, Elena Frantsiyants, Oleg Kit, Erica Golemis, Yanis Boumber, Punita Dhawan. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression. PLOS ONE 2021; 16(7) doi: 10.1371/journal.pone.0252132
|
| 413 |
Rahaba Marima, Flavia Zita Francies, Rodney Hull, Thulo Molefi, Meryl Oyomno, Richard Khanyile, Sikhumbuzo Mbatha, Mzubanzi Mabongo, David Owen Bates, Zodwa Dlamini. MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets. Biomedicines 2021; 9(12) doi: 10.3390/biomedicines9121818
|
| 414 |
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, Domenico Mangiameli, Serena Contarelli, Silvia Pietrobono, Davide Melisi. The Multifaceted Role of TGF-β in Gastrointestinal Tumors. Cancers 2021; 13(16) doi: 10.3390/cancers13163960
|
| 415 |
Wei Zhang, Qian Shi, Qincheng Liu, Haomiao Zhang, Ji Xia, Xueli Zhang. Angio‐associated migratory cell protein promotes colorectal cancer progression by enhancing phosphoglycerate kinase 1 phosphorylation. Journal of Cell Communication and Signaling 2025; 19(2) doi: 10.1002/ccs3.70023
|
| 416 |
Elnaz Ghorbani, Amir Avan, Mikhail Ryzhikov, Gordon Ferns, Majid Khazaei, Saman Soleimanpour. Role of lactobacillus strains in the management of colorectal cancer: An overview of recent advances. Nutrition 2022; doi: 10.1016/j.nut.2022.111828
|
| 417 |
Matilda Holm, Emma Andersson, Emerik Osterlund, Ali Ovissi, Leena-Maija Soveri, Anna-Kaisa Anttonen, Soili Kytölä, Kristiina Aittomäki, Pia Osterlund, Ari Ristimäki, Elizabeth Christie. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PLOS ONE 2020; 15(11) doi: 10.1371/journal.pone.0239819
|
| 418 |
Qing Zhang, Yue Zhou, Xingyu Feng, Yuan Gao, Chengzhi Huang, Xueqing Yao. Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer. Biomedicine & Pharmacotherapy 2022; 153 doi: 10.1016/j.biopha.2022.113426
|
| 419 |
Amirsaeed Sabeti Aghabozorgi, Samaneh Sharif, Reza Jafarzadeh-Esfehani, Saba Vakili, Mohammad Reza Abbaszadegan. Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal Cancer. Pharmacogenomics 2021; 22(5) doi: 10.2217/pgs-2020-0159
|
| 420 |
Weijia Zhang, Ling Ou, Chang Peng, Shuyi Sang, Zhong Feng, Yuanjing Zou, Yuemei Yuan, Hao Li, Guimin Zhang, Meicun Yao. Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways. Heliyon 2023; 9(6) doi: 10.1016/j.heliyon.2023.e16798
|
| 421 |
Saeideh Khorshid Sokhangouy, Hamid Jamialahmadi, Mahdieh Sadat Mortazavi Sani, Ghazaleh Khalili-Tanha, Arian Karimi Rouzbahani, Golnaz Mahmoudvand, Zahra Goudarzi, Arshia Fakouri, Simin Farokhi, Seyed Mahdi Hassanian, Gordon A Ferns, Elham Nazari, Amir Avan, Majid Khazaei. The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer. Current Cancer Drug Targets 2025; 25(10) doi: 10.2174/0115680096319027240820055043
|
| 422 |
Shuilong Fang, Huicun Cao, Jian Liu, Guangshao Cao, Tianxiao Li. Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells. International Immunopharmacology 2024; 141 doi: 10.1016/j.intimp.2024.112896
|
| 423 |
Xiuzhang Yan, Heshi Liu, Lei Guo, Chang Liu, Shichen Zhang, Xue Wang, Yixin Tang, Rui Zhou, Xin Jiang, Erlei Wang, Shuohui Gao, Caina Xu. Multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy against colorectal cancer through synergistic cuproptosis/ferroptosis/apoptosis. Materials Today Bio 2025; 30 doi: 10.1016/j.mtbio.2024.101427
|
| 424 |
Mingyi Huo, Zhixu Gao, Guizhen Wang, Zhiping Hou, Jining Zheng. Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt/β‑catenin signaling pathway. Oncology Reports 2024; 53(1) doi: 10.3892/or.2024.8840
|
| 425 |
Nelly N. Miteva-Marcheva, Hristo Y. Ivanov, Dimitar K. Dimitrov, Vili K. Stoyanova. Application of pharmacogenetics in oncology. Biomarker Research 2020; 8(1) doi: 10.1186/s40364-020-00213-4
|
| 426 |
Egle Katkeviciute, Larissa Hering, Ana Montalban-Arques, Philipp Busenhart, Marlene Schwarzfischer, Roberto Manzini, Javier Conde, Kirstin Atrott, Silvia Lang, Gerhard Rogler, Elisabeth Naschberger, Vera S. Schellerer, Michael Stürzl, Andreas Rickenbacher, Matthias Turina, Achim Weber, Sebastian Leibl, Gabriel E. Leventhal, Mitchell Levesque, Onur Boyman, Michael Scharl, Marianne R. Spalinger. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development. Journal of Clinical Investigation 2021; 131(1) doi: 10.1172/JCI140281
|
| 427 |
Leila M. Abbass, Mustapha Belaidi, Saleh M. Bufarwa, Sadeek A. Sadeek. Exploring the anti-colon cancer potential of febuxostat-based mixed metal complexes with 2,2′-bipyridine: MTT assay, toxicity evaluation, prediction profiles, and computational studies. Inorganic Chemistry Communications 2025; 178 doi: 10.1016/j.inoche.2025.114460
|
| 428 |
Mina Raileanu, Aurel Popescu, Mihaela Bacalum. Antimicrobial Peptides as New Combination Agents in Cancer Therapeutics: A Promising Protocol against HT-29 Tumoral Spheroids. International Journal of Molecular Sciences 2020; 21(18) doi: 10.3390/ijms21186964
|
| 429 |
Elda Chiaino, Matteo Micucci, Miriam Durante, Roberta Budriesi, Roberto Gotti, Carla Marzetti, Alberto Chiarini, Maria Frosini. Apoptotic-Induced Effects of Acacia Catechu Willd. Extract in Human Colon Cancer Cells. International Journal of Molecular Sciences 2020; 21(6) doi: 10.3390/ijms21062102
|
| 430 |
Walid L. Shaib, Ganji Purnachandra Nagaraju, Batoul Farran, Gregory B. Lesinski, Bassel F. El-Rayes. Interaction of heat shock protein 90 with hypoxia inducible factor and signal transducer and activator of transcription in colon cancer. Process Biochemistry 2019; 86 doi: 10.1016/j.procbio.2019.07.015
|
| 431 |
Kevin Van der Jeught, Yifan Sun, Yuanzhang Fang, Zhuolong Zhou, Hua Jiang, Tao Yu, Jinfeng Yang, Malgorzata M. Kamocka, Ka Man So, Yujing Li, Haniyeh Eyvani, George E. Sandusky, Michael Frieden, Harald Braun, Rudi Beyaert, Xiaoming He, Xinna Zhang, Chi Zhang, Sophie Paczesny, Xiongbin Lu. ST2 as checkpoint target for colorectal cancer immunotherapy. JCI Insight 2020; 5(9) doi: 10.1172/jci.insight.136073
|
| 432 |
Qixuan Feng, Yue Sun, Zhe Yang, Zhiyu Wang, Zhangyi Chen, Fang Liu, Lingxiang Liu. Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1522919
|
| 433 |
The Effective Role of Targeted Therapy in Advanced Colorectal Cancer. Al Mustansiriyah Journal of Pharmaceutical Sciences 2022; 22(2) doi: 10.32947/ajps.v22i2.835
|
| 434 |
Songhua Bei, Qingyu Xu, Fan Li, Chenqu Wu, Qi Sun, Li Feng. Brefeldin A: A newly identified cell death inducer selectively targets radio-resistant colorectal cancer cells by direct interacting with caspase-3. Journal of King Saud University - Science 2022; 34(2) doi: 10.1016/j.jksus.2021.101728
|
| 435 |
Chun Ge, Xintong Huang, Sujie Zhang, Man Yuan, Zhaoyi Tan, Chen Xu, Qiong Jie, Jingjing Zhang, Jianjun Zou, Yubing Zhu, Dong Feng, Yue Zhang, Jiye Aa. In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02853-6
|
| 436 |
Yu Han, Yuan Qing Qu, Simon Wing Fai Mok, Juan Chen, Cheng Lai Xia, Hu Qiang He, Zheng Li, Wei Zhang, Cong Ling Qiu, Liang Liu, Betty Yuen Kwan Law, Vincent Kam Wai Wong. A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00912
|
| 437 |
Huixia Fan, Xiaopeng Hao, Yuan Gao, Jian Yang, Aojun Liu, Yarui Su, Yong Xia. Nodosin Exerts an Anti-Colorectal Cancer Effect by Inhibiting Proliferation and Triggering Complex Cell Death in Vitro and in Vivo. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.943272
|
| 438 |
Aranka Brockmueller, Anjana Sajeev, Lenka Koklesova, Samson Mathews Samuel, Peter Kubatka, Dietrich Büsselberg, Ajaikumar B. Kunnumakkara, Mehdi Shakibaei. Resveratrol as sensitizer in colorectal cancer plasticity. Cancer and Metastasis Reviews 2024; 43(1) doi: 10.1007/s10555-023-10126-x
|
| 439 |
Chen Chen, Jens Neumann, Florian Kühn, Serene M. L. Lee, Moritz Drefs, Joachim Andrassy, Jens Werner, Alexandr V. Bazhin, Tobias S. Schiergens. Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer. Cancers 2020; 12(10) doi: 10.3390/cancers12103007
|
| 440 |
Qibing Chen, Yan Wang, Fen Li, Xiang Cheng, Yu Xiao, Shiming Chen, Bokui Xiao, Zezhang Tao. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(6) doi: 10.2174/1871520621666210706101442
|
| 441 |
Gloria Yareli Gutierrez-Silerio, Pablo Garcia-Solis, Elhadi M. Yahia, José David Núñez-Ríos, Francisco Vázquez-Cuevas, Pablo Alan Rodriguez-Salinas, Rolando Mendoza-Zuñiga, Aaron Kuri-García. Cytotoxic and Antitumoral Effects of Methanolic Extracts of Avocado Fruit Mesocarp in Colorectal Cancer Cell Line HT29. Journal of Medicinal Food 2024; 27(3) doi: 10.1089/jmf.2023.0112
|
| 442 |
Gang Wang, Jun-Jie Wang, Zhu Zhi-Min, Xiao-Na Xu, Feng Shi, Xing-Li Fu. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer. Science Progress 2023; 106(1) doi: 10.1177/00368504221147173
|
| 443 |
Zuo Tan, Lili Jiang, Anqing Lu, Xiao He, Yan Zuo, Jie Yang. Living with a permanent ostomy: a descriptive phenomenological study on postsurgical experiences in patients with colorectal cancer. BMJ Open 2024; 14(11) doi: 10.1136/bmjopen-2024-087959
|
| 444 |
Gozde Hasbal‑Celikok, Pinar Aksoy‑sagirli, Gulsum Altiparmak‑Ulbegi, Ayse Can. Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment. Oncology Letters 2021; 21(3) doi: 10.3892/ol.2021.12470
|
| 445 |
Martina Muste Sadurni, Marco Saponaro. Deregulations of RNA Pol II Subunits in Cancer. Applied Biosciences 2023; 2(3) doi: 10.3390/applbiosci2030029
|
| 446 |
Yunlong Li, Zhiyuan Liu, Ping Wang, Xuerong Gu, Fei Ling, Jiayuan Zhong, Dong Yin, Rui Liu, Xueqing Yao, Chengzhi Huang. Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer. Advanced Healthcare Materials 2025; 14(6) doi: 10.1002/adhm.202403531
|
| 447 |
Xiao Tan, Zhongqiang Zhang, Ping Liu, Hongliang Yao, Liangfang Shen, Jing-Shan Tong. RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer. Cell Death & Disease 2020; 11(12) doi: 10.1038/s41419-020-03266-3
|
| 448 |
Yordan Sbirkov, Diana Molander, Clement Milet, Ilia Bodurov, Boyko Atanasov, Radoslav Penkov, Nikolay Belev, Nico Forraz, Colin McGuckin, Victoria Sarafian. A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.755563
|
| 449 |
Maria H. Ribeiro, Patricia Lage. Handbook of Dietary Flavonoids. 2023; doi: 10.1007/978-3-030-94753-8_29-1
|
| 450 |
Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino, Carlo Leonetti, Giuliana Di Rocco, Alessandra Verdina, Francesca Spinella, Francesco Fiorentino, Gennaro Ciliberto, Annamaria Biroccio, Pasquale Zizza. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01612-z
|
| 451 |
Laura Mosca, Martina Pagano, Annalisa Pecoraro, Luigi Borzacchiello, Luigi Mele, Giovanna Cacciapuoti, Marina Porcelli, Giulia Russo, Annapina Russo. S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells. International Journal of Molecular Sciences 2020; 22(1) doi: 10.3390/ijms22010103
|
| 452 |
Tu Hong, Xinyuan Shen, Madiha Zahra Syeda, Yang Zhang, Haonan Sheng, Yipeng Zhou, JinMing Xu, Chaojie Zhu, Hongjun Li, Zhen Gu, Longguang Tang. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy. Nano Research 2023; 16(2) doi: 10.1007/s12274-022-5002-2
|
| 453 |
Avik Sengupta, Saurabh Kumar Singh, Rahul Kumar. Support Vector Machine-Based Prediction Models for Drug Repurposing and Designing Novel Drugs for Colorectal Cancer. ACS Omega 2024; 9(16) doi: 10.1021/acsomega.4c01195
|
| 454 |
Thanwarat Winitchaikul, Suphunwadee Sawong, Damratsamon Surangkul, Metawee Srikummool, Julintorn Somran, Dumrongsak Pekthong, Kittiya Kamonlakorn, Pranee Nangngam, Supawadee Parhira, Piyarat Srisawang, Mukesh Singh Sikarwar. Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0254392
|
| 455 |
Yuying Li, Wei Yan, Yu Qin, Liwei Zhang, Sheng Xiao. The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K/AKT/mTOR Pathway. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126468
|
| 456 |
Kelly Offermans, Josien C. A. Jenniskens, Colinda C. J. M. Simons, Iryna Samarska, Gregorio E. Fazzi, Kim M. Smits, Leo J. Schouten, Matty P. Weijenberg, Heike I. Grabsch, Piet A. van den Brandt. Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes. Journal of Cancer Research and Clinical Oncology 2023; 149(9) doi: 10.1007/s00432-023-04581-w
|
| 457 |
Shi-Jie Zeng, Ke He, Zhi Shi. Targeting the ZMYM2–ANXA9 Axis: Organoid Models Illuminate a Novel Pathway to Overcome Oxaliplatin Resistance in Colorectal Cancer. Biomedicines 2025; 13(11) doi: 10.3390/biomedicines13112804
|
| 458 |
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby. Engineered Nanomedicines for Augmenting the Efficacy of Colorectal Cancer Immunotherapy. Nanomedicine 2022; 17(22) doi: 10.2217/nnm-2022-0214
|
| 459 |
Bangli Hu, Yixin Yin, Birong Zhang, Siqi Li, Kezhi Li, You Zhou, Qinghua Huang. Villin‐1 regulates ferroptosis in colorectal cancer progression. The FEBS Journal 2025; 292(7) doi: 10.1111/febs.17350
|
| 460 |
Xinhui Fu, Hanjie Lin, Xinjuan Fan, Yaxi Zhu, Chao Wang, Zhiting Chen, Xiaoli Tan, Jinglin Huang, Yacheng Cai, Yan Huang. The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.595675
|
| 461 |
Sanjukta Sen, Sreemoyee Mitra, Dipanjan Karati. Targeting drug resistance in colorectal cancer using peptide-based scaffolds: new frontiers in colorectal cancer therapy. Nanomedicine 2026; 21(5) doi: 10.1080/17435889.2026.2628241
|
| 462 |
L. E. Anselmino, M. V. Baglioni, F. Malizia, N. Cesatti Laluce, C. Borini Etichetti, V. L. Martínez Marignac, V. Rozados, O. G. Scharovsky, J. Girardini, M. J. Rico, M. Menacho Márquez. Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87525-z
|
| 463 |
Mimmo Turano, Paolo Delrio, Daniela Rega, Francesca Cammarota, Alessia Polverino, Francesca Duraturo, Paola Izzo, Marina De Rosa. Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy. Cancers 2019; 11(12) doi: 10.3390/cancers11121932
|
| 464 |
Hao Chen, Chongya Zhai, Xian Xu, Haidong Wang, Weidong Han, Jiaying Shen. Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis. Cancers 2023; 16(1) doi: 10.3390/cancers16010059
|
| 465 |
Giulia Rizzo, Andrea Bertotti, Simonetta Maria Leto, Stefania Vetrano. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01970-2
|
| 466 |
P. E. Maksimova, E. P. Golubinskaya, B. D. Seferov, E. Yu. Zyablitskaya. Colorectal cancer: epidemiology, carcinogenesis, molecular subtypes and cellular mechanisms of therapy resistance (analytical review). Koloproktologia 2023; 22(2) doi: 10.33878/2073-7556-2023-22-2-160-171
|
| 467 |
Diana Cenariu, Alina-Andreea Zimta, Raluca Munteanu, Anca Onaciu, Cristian Silviu Moldovan, Ancuta Jurj, Lajos Raduly, Alin Moldovan, Adrian Florea, Liviuta Budisan, Laura Ancuta Pop, Lorand Magdo, Mihai Tudor Albu, Rares Bogdan Tonea, Mihai-Stefan Muresan, Calin Ionescu, Bogdan Petrut, Rares Buiga, Alexandru Irimie, Diana Gulei, Ioana Berindan-Neagoe. Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene. Pharmaceutics 2021; 13(5) doi: 10.3390/pharmaceutics13050664
|
| 468 |
Yuan Zhang, Aurore Devocelle, Christophe Desterke, Lucas Eduardo Botelho de Souza, Éva Hadadi, Hervé Acloque, Adlen Foudi, Yao Xiang, Annabelle Ballesta, Yunhua Chang, Julien Giron-Michel. BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105247
|
| 469 |
Jiao Wei, Zongmei Zheng, Xinxin Hou, Fengjing Jia, Yuan Yuan, Fuwen Yuan, Feng He, Liang Hu, Ling Zhao. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway. Journal of Ethnopharmacology 2024; 318 doi: 10.1016/j.jep.2023.116866
|
| 470 |
Mahdi Farhoudi Sefidan Jadid, Davoud Jafari-Gharabaghlou, Mohammad Kazem Bahrami, Esat Bonabi, Nosratollah Zarghami. Enhanced anti-cancer effect of curcumin loaded-niosomal nanoparticles in combination with heat-killed Saccharomyces cerevisiae against human colon cancer cells. Journal of Drug Delivery Science and Technology 2023; 80 doi: 10.1016/j.jddst.2023.104167
|
| 471 |
Recent Advancement in Nanotechnological Approaches for Increasing the Effectiveness of Herbal Drugs in the Treatment of Colorectal Cancer. Current Cancer Therapy Reviews 2025; 21(2) doi: 10.2174/0115733947279599231208095726
|
| 472 |
Dipanjan Karati, Swarupananda Mukherjee, Biswajit Basu, Kevin Kumar Garala, Ayon Dutta, Bhupendra G. Prajapati, Sankha Bhattacharya. Unlocking the Potential of RNA Nanoparticles: A Breakthrough Approach to Overcoming Challenges in Colon Cancer Treatment. Current Pharmaceutical Biotechnology 2025; 26(7) doi: 10.2174/0113892010285554240303160500
|
| 473 |
Seok-Jun Mun, Euni Cho, Jae-Sung Kim, Chul-Su Yang. Pathogen-derived peptides in drug targeting and its therapeutic approach. Journal of Controlled Release 2022; 350 doi: 10.1016/j.jconrel.2022.08.041
|
| 474 |
Yu Xiao, Hancui Lin, Jinluan Li, Junxin Wu. Disulfidptosis-related prognostic signature correlates with immunotherapy response in colorectal cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-49954-w
|
| 475 |
Surachai Maijaroen, Sompong Klaynongsruang, Sittiruk Roytrakul, Monruedee Konkchaiyaphum, Lapatrada Taemaitree, Nisachon Jangpromma. An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon Cancer (Caco-2) Cells. Molecules 2022; 27(4) doi: 10.3390/molecules27041426
|
| 476 |
Azadehdokht Eftekhari Fumani, Masoumeh Anvari, Meysam Hasannejad-Bibalan, Robabeh Sayyadi Kordabadi. Overexpression of CASP-3, CASP-8, CASP-9 and P53 in HT-29 Cancer Cells after Co-Treatment of New Strain of Lactobacillus Crispatus Extract and Doxorobixin and Complementary Docking Study. Current Microbiology 2026; 83(1) doi: 10.1007/s00284-025-04617-z
|
| 477 |
Azza Abusree Ahmed, Manar Monir, Dina Sabry, Abeer Mostafa. In vitro study to evaluate the effect of granulocyte colony stimulating factor on colorectal adenocarcinoma and on mesenchymal stem cells trans differentiation into cancer stem cells by cancer cells derived exosomes. Beni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-023-00351-2
|
| 478 |
Sergej Kudruk, Sharafudheen Pottanam Chali, Anna Livia Linard Matos, Cole Bourque, Clara Dunker, Christos Gatsogiannis, Bart Jan Ravoo, Volker Gerke. Biodegradable and Dual‐Responsive Polypeptide‐Shelled Cyclodextrin‐Containers for Intracellular Delivery of Membrane‐Impermeable Cargo. Advanced Science 2021; 8(18) doi: 10.1002/advs.202100694
|
| 479 |
Danyang Wang, Bin Li, Guojie Shen, Hangyu Zhang, Yang Gao, Zhicheng Du, Xiaomeng Dai, Xuanwen Bao, Xudong Zhu, Zhou Tong, Dongxue Hu, Lulu Liu, Yi Zheng, Peng Zhao, Shu Wang, Weijia Fang. NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study. Cancer Immunology, Immunotherapy 2025; 74(11) doi: 10.1007/s00262-025-04196-9
|
| 480 |
Crescenzo Massaro, Elham Safadeh, Giulia Sgueglia, Hendrik G. Stunnenberg, Lucia Altucci, Carmela Dell’Aversana. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance. Cells 2020; 10(1) doi: 10.3390/cells10010039
|
| 481 |
Nour K. Younis, Rami Roumieh, Emmanuel P. Bassil, Joseph A. Ghoubaira, Firas Kobeissy, Ali H. Eid. Nanoparticles: Attractive tools to treat colorectal cancer. Seminars in Cancer Biology 2022; 86 doi: 10.1016/j.semcancer.2022.08.006
|
| 482 |
Maryam Akbarzadeh, Maryam Majidinia, Gholamreza Dehghan. ATR inhibition by M-4344 reverses 5-fluorouracil resistance in colorectal cancer cells through enhanced DNA damage and suppression of PI3K/AKT signaling. Gene Reports 2026; 43 doi: 10.1016/j.genrep.2026.102487
|
| 483 |
Lara J. Bou Malhab, Wael M. Abdel-Rahman. Obesity and Inflammation: Colorectal Cancer Engines. Current Molecular Pharmacology 2022; 15(4) doi: 10.2174/1874467214666210906122054
|
| 484 |
Qi Liu, Xiaoyong Li, Tiejun Jin, Sibo Huo, Shuai Su, Nan Liu. Liquid Biopsy in CRC Management: Early Detection, Minimal Residual Disease, and Therapy Optimization—Clinical Evidence and Challenges. Diagnostic Cytopathology 2025; 53(11) doi: 10.1002/dc.70009
|
| 485 |
Ko-Chao Lee, Kuen-Lin Wu, Shun-Fu Chang, Hsin-I Chang, Cheng-Nan Chen, Yih-Yuan Chen. Fermented Ginger Extract in Natural Deep Eutectic Solvent Enhances Cytotoxicity by Inhibiting NF-κB Mediated CXC Chemokine Receptor 4 Expression in Oxaliplatin-Resistant Human Colorectal Cancer Cells. Antioxidants 2022; 11(10) doi: 10.3390/antiox11102057
|
| 486 |
Bo Zhang, Sze‐Hoi Chan, Xue‐Qi Liu, Yuan‐Yuan Shi, Zhao‐Xia Dong, Xin‐Rong Shao, Li‐Yuan Zheng, Zhi‐Ying Mai, Tian‐Liang Fang, Li‐Zhi Deng, Di‐Sheng Zhou, Shu‐Na Chen, Miao Li, Xing‐Ding Zhang. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer. Journal of Cellular and Molecular Medicine 2021; 25(18) doi: 10.1111/jcmm.16842
|
| 487 |
Milad Moloudizargari, Jamal Rahmani, Mohammad Hossein Asghari, Ajay Goel. The Prognostic Role of miR-31 in Colorectal Cancer: The Results of a Meta-Analysis of 4720 Patients. Epigenomics 2022; 14(2) doi: 10.2217/epi-2021-0277
|
| 488 |
Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; doi: 10.1007/978-3-030-72702-4_7
|
| 489 |
Alessandra Verdina, Alessia Garufi, Valerio D’Orazi, Gabriella D’Orazi. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies. International Journal of Molecular Sciences 2024; 25(14) doi: 10.3390/ijms25147678
|
| 490 |
Nima Rastegar-Pouyani, Jaber Zafari, Alireza Nasirpour, Hossein Vazini, Nabaa Najjar, Seyedeh Zohreh Azarshin, Fatemeh Javani Jouni. Methylene Blue-Mediated Photodynamic Therapy in Combination With Doxorubicin: A Novel Approach in the Treatment of HT-29 Colon Cancer Cells. Journal of Lasers in Medical Sciences 2024; 15 doi: 10.34172/jlms.2024.64
|
| 491 |
Victor Kuete. African plant-based products as a source of potent drugs to overcome cancers and their chemoresistance Part 1. Cancer chemoresistance, screening methods, and the updated cut-off points for the classification of natural cytotoxic products. Advances in Botanical Research 2024; 111 doi: 10.1016/bs.abr.2023.12.002
|